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Abstract 
 
Graham J. Haun 
EFFORTS TOWARDS THE DISCOVERY OF NOVEL METHODS FOR THE 
SYNTHESIS OF PHARMACOLOGICALLY RELEVANT MOLECULAR 
SCAFFOLDS 
2017-2018 
Dr. Gustavo Moura-Letts 
Master of Science in Pharmaceutical Sciences 
 
 
 With the introductions of pharmaceuticals into modern day society many people 
have been using them to improve their lives. Due to this high increase in demand along 
with the ever-growing concern of environmental impact pharmaceutical companies have 
been pressed to synthesis new and existing drugs at a higher rate. This increased rate can 
cause low yield drugs or have a heavy environmental impact. As the use of 
pharmaceuticals becomes more widespread the need for greener and simpler organic 
synthesis methods to make these pharmaceuticals becomes more needed. 
 Herein is reported the methodological development of different 
pharmacologically relevant scaffolds. This work shows Titanium Dioxide (TiO2, rutile) 
as well as Hydroxylamine-O-Sulfonic Acid (HOSA) can be employed to make a scaffold 
that is commonly used for the synthesis of amino acids. This work also presents two 
methods for the formation of heterocyclic compounds that have been found to have 
antibacterial properties. These works highlight the value of simple methodology to 
achieve relevant scaffolds for pharmaceuticals.     
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1 
Chapter 1 
 
Sulfonylamidonitriles 
 
1.1 Introduction to the Strecker Reaction and Titanium Dioxide 
Scaffolds that contain an aminonitrile are of significant importance in organic 
chemistry1, 2, and are typically prepared through a nucleophilic addition of a cyanide to an 
imine known as the Strecker reaction.3-5 The Strecker reaction allows for the formation of 
pharmaceutically relevant molecular scaffolds such as α-amino acids (Figure 1).6-8 
 
 
 
 
Figure 1. Various modes of α-aminonitrile activity 
 
 
 
2 
Traditionally the Strecker reaction is carried out with the use of bulky and expensive 
catalysts9-11 (Figure 2) that are efficient but tend to be toxic and are the cause of wasteful 
and tedious workups.12, 13 Ti-catalyzed Strecker reactions are commonly run in toluene 
using 10% mol of the Ti-catalyst. These conditions allow for the increase of 
enantioselectivity and stereoselectivity, at -20˚C, of the nitrile formed. The 
stereoselectivity was also seen to decrease upon heating usually around 0-10˚C. Different 
heterogenous catalysts in the presence of polymeric sulfuric acid14, molecular sieves15, 
nanosized material16, heteropolyacids, and supported complexes have all shown to 
improve the efficiency of this reaction in terms of cost, recovery, and separation but the 
toxicity and waste management still persist.17-20 
 
 
 
 
Figure 2. Nitrile Synthesis Using an Aluminum Catalyst 
 
 
 
 The synthesis of sulfonylamidonitriles relies on the nucleophilic addition of 
cyanide to a sulfonylimine (Figure 3) which is an important Strecker-type reaction.21-23 
3 
Other methods for the synthesis of these scaffolds have relied on organic sources of 
cyanide and transition metals in order to achieve higher levels of selectivity and 
efficiency.24-26 These transition metals included an La-catalyst using HCN as the cyanide 
source. The La-catalyst dissolved more in EtCN than toluene while still providing the 
same enantioselectivity. This lead to high enantioselectivity of the nitrile with α,β-
Unsaturated aldimines while aliphatic aldimines gave poor enantioselectivity. These 
reactions ran the catalyst in 10 mol percent while the reaction ran at -20˚C for 20 hours. 
The La-catalyst was also poorly activated and needed upwards of 50 mol percent of an 
additive to achieve the desired enantioselectivity. Due to the high cost and toxicity of 
these reagents attention has shifted to the development of cyanide sources that are less 
expensive and toxic while being easy to dispose of.27-29 
 
 
 
 
Figure 3. General Structure of a Sulfonylimine 
 
 
 
 It has been shown that titanium dioxide (TiO2, rutile) can be used as a catalyst 
support30 and allows for the modulation of catalytic activities such as dehydrogenation 
and hydrodesulfurization.31-33 Rutile nanoparticles have been used as a catalyst to 
4 
synthesize quinolinones via a domino hydrolysis/ aldol condensation/ Michael addition 
reaction.34 Rutile is the mineral form of titanium dioxide, which is the most abundant 
natural source of titanium.35, 36 The nontoxic nature as well as the high physical and 
chemical stability have led to rutile being researched in a wide variety of fields.37 
 
1.2 Results and Discussion 
With the knowledge that sulfonylamidonitriles formation is usually not a green 
reaction, we set out to find optimal conditions in which this reaction would be a one pot 
green reaction. Optimization began with the addition of excess sulfonamide (Table 1, 
Entry 1). This showed high conversion to the imine but a low conversion to the product. 
Phase transfer catalysts have commonly been used in Strecker reactions and through the 
addition of tetrabutylammonium iodide (TBAI) in the solvent tetrahydrofuran (THF) the 
yield of the reaction increased significantly (Table 1, Entry 5). Lewis acids have also 
been known to promote Strecker reactions and found that decreasing the strength of the 
Lewis acid promoted the reaction further showing that rutile was the best promoter 
(Table 1, Entry 7, 9 ,10-11). Other metal oxides were than tested and it was observed that 
rutile was the best promoter (Table 1, Entry 13-16). Upon changing the stoichiometric 
amounts of rutile, the optimal conditions were arrived upon (Table 1, Entry 19). 
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Table 1 
Sulfonylamindonitrile Synthesis Optimization Studies 
Solvent Conversionb Yield 2cPromoterEntry
THF
[SultoneTMG]
1
2
7
6
8
13
11
14
10
9
5
3
4
12
Reaction conditions: tolualdehyde (0.1 mmol), toluenesulfonamide (0.1 mmol) and rutile (0.02 mmol)
were mixed in H2O and then NaCN (0.2 mmol) was added as a 4M H2O solution.
a) Molar ratio: Aldehyde:Sulfonamide:Rutile:NaCN. b)Reaction conversion measured by 1H NMR.
c) Isolated yield. d) TiO2 as Rutile. e) TiO2 as Anatase. f) Reaction with 1 equiv. of NaHCO3.
-
-
-
-
90% 64%
88% 50%
93% 66%
84% 55%
95% 68%
71%
89%
78% 40%
59%
62%
88% 75%
95% 89%
82% 55%
90% 90%
95% 75%
99% 97%
S
OO
NH2
O
+
S
OO
N
H
CN
S
OO
N +
H2O
molar ratioa
CHCl3
THF/H2O
CN
CHCl3
NaCN
cyanohydrin
TMSCN
NaCN
TBAI NaCNTHF
1:2:1:2
1:2:1:2
1:2:1:2
1:2:1:2
1:2:1:2
THF/H2O NaCN1:1:1:2
TiCl4 1:1:1:2 cyanohydrin
THF Ti(EtO)4 1:1:1:2 cyanohydrin
THF Ti(EtO)4/TBAI 1:1:1:2 NaCN
THF TiO2
c 1:1:1:2 NaCN
TiO2/TBAI
c 1:1:1:2 NaCN
H2O
THF
TiO2
d 1:1:1:2 NaCN
ZrO2 1:1:1:2 NaCN
Fe2O3 1:1:1:2 NaCN
21
conditions
TBAI
H2O
H2O
15
16
99% 92%
99% 93%
TiO2
d 1:1:0.5:2 NaCN
TiO2
d 1:1:0.2:2 NaCN
H2O
H2O
17
18
80% 71%
80% 62%
TiO2
d 1:1:0.1:2 NaCN
TiO2
d 1:1:0.2:1f NaCN
H2O
H2O
19
80% 71%ZnO 1:1:1:2 NaCNH2O
20
21
88% 64%
95% 82%
MgO 1:1:1:2 NaCN
TiO2
e 1:1:1:2f NaCN
H2O
H2O
 
 
 
 
 With the optimal conditions in hand we moved on to test the scope of this 
reaction. It was found that aliphatic aldehydes converted to the nitrile in excellent yields 
6 
(Table 2, Entry 1-3). Aromatic aldehydes also proved to have excellent yields including 
cinnamaldehyde (Table 2, Entry 4-11). As expected electron donating groups proved to 
have excellent yields with this method (Table 2, Entry 6-7). Electron withdrawing groups 
also proved to have good yields (Table 2, Entry 10-11). Molecules with electron 
withdrawing groups were observed to perform background reactions and required 
purification through a silica gel column. 
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Table 2 
Sulfonylamindonitrile Synthesis Scope 
 
 
 
 
 Tests to determine the scope of sulfonamides were done using cinnamaldehyde 
due to them having the greatest yields. Pharmacologically relevant sulfonamides were 
tested and found to have excellent yields (Table 3, Entry 2-3). High chirality transfer was 
testing using t-buytlsulfonamide and the reaction showed poor yields (Table 3, Entry 4). 
8 
Tests were done on other aldehydes with the test sulfonamides to see if the reactions 
would still proceed in high yields (Table 3, Entry 5-9). 
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Table 3 
Sulfonylamidonitrile Sulfonamide Synthesis Scope 
 
 
 
 
10 
 The recyclability of the rutile as a catalyst was tested and was found that after 
four cycles of reuse the time required for the reaction to complete increased (Table 4, 
Entry 4). After six cycles the yield of the reaction decreased slightly (Table 4, Entry 6) 
while, by cycle ten the reaction was no longer viable (Table 4, Entry 10).  
 
 
 
Table 4 
Sulfonylamidonitrile Rutile Recyclability Study 
 
 
 
 
 The reaction mechanism starts with the chelation of rutile to each oxygen 
molecule (Figure 4). After this the primary amine of the sulfonamide attacks the carbonyl 
carbon and pushes the electrons up to the oxygen. After proton transfer the lone pair on 
the amine pushes toward the carbon-nitrogen bond and displaces water. This forms an 
11 
imine that can now be attacked by the cyanide which, after proton transfer and an 
aqueous workup forms the final sulfonylamidonitrile product. 
 
 
 
 
Figure 4. Proposed Mechanism of the Sulfonylamidonitrile Reaction 
 
 
 
1.3 Conclusion 
This method shows the development of an efficient and novel synthesis of 
sulfonylamidonitriles in the presence of rutile as a catalyst. The data provided shows that 
aliphatic and aromatic aldehydes undergo this reaction in excellent yields with complete 
conversion. Moreover, the presented data shows that a variety of substituted sulfonamides 
are ideal for this reaction. Rutile has also been shown through these experiments to be 
12 
easily recovered and reused for 8 cycles with no significant loss of productivity. The 
proposed mechanism also postulates that rutile provides a Lewis acidic environment that 
allows for multiple interaction sites on the rutile, enhancing the rate of cyanide addition 
across the imine intermediate. 
 
1.4 Experimental 
Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar and 
used without further purification. Solvents were obtained from EMD Miliphore DrySol 
and degassed with nitrogen. Reactions were performed in 4-mL glass vials with magnetic 
stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized 
under UV light (254 nm) or by staining with potassium permanganate (KMnO4). Silica 
flash chromatography was performed on E. Merck 230-400 mesh silica gel 60. Automated 
chromatography was performed on an ISOLERA Prime instrument with 10 g. SNAP silica 
gel normal phase cartridges using a flow rate of 12.0 mL/min and a gradient of 0- 30% 
EtOAc in Heptanes over 12 column volumes with UV detection at 254 nm. NMR spectra 
were recorded on Varian Mercury II 400 MHz Spectrometer at 9 24 °C in CDCl3 unless 
otherwise indicated. Chemical shifts are expressed in ppm relative to solvent signals: 
CDCl3 (
1H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed in Hz. 
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1.4.1. General method for the synthesis of Sulfonylamidonitriles. In a 4-mL 
reaction vial, aldehyde (0.1 mmol, 1.0 equiv), sulfonaamide (0.1 mmol, 1.0 equiv.), ruitle 
(0.02 mmol, 0.2 equiv) were dissolved in a 4 mL solution of de-ionized H2O with (0.2 
mmol, 2 equiv) NaCN. The solution was stirred at RT for 3 h or until complete conversion, 
determined by TLC. The reaction was concentrated by rotary evaporation to afford the 
crude product. The product was directly characterized unless traces of impurities required 
purification by automated silica gel flash chromatography (few examples). 
 
1.4.2. Synthesis of Sulfonylamidonitriles from Table 2. 
 
 
N-(1-cyanooctyl)-4-methylbenzenesulfonamide (2a): Sulfonylamidonitrile 2a was 
obtained (27 mg, 88%) as a pale-yellow oil. TLC: Rf 0.64 (2:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3): d 7.76 (d, J = 7.5 Hz, 2H), 7.28 (d, J = 7.5 Hz, 2H), 4.22 (t, J 
= 7.1 Hz, 1H), 2.48 (s, 3H), 1.75 (ddd, J = 7.3, 6.9, 6.4 Hz, 2H), 1.48-1.44 (m, 2H), 1.27-
1.23 (m, 8H), 0.82 (t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 144.6, 136.0, 
130.1, 127.2, 117.5, 44.4, 34.0, 31.6, 28.8, 28.5, 25.0, 22.6, 21.6, 14.0 ppm. ESI-MS m/z 
(rel int): (pos) 309.1 ([M+H]+, 100); (neg) 307.1 ([M−H]-, 100). 
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N-(1-cyanohexyl)-4-methylbenzenesulfonamide (2b): Sulfonylamidonitrile 2b was 
obtained (25 mg, 91%) as a colorless oil. TLC: Rf 0.64 (2:1 heptanes/EtOAc). 1H NMR 
(400 MHz, CDCl3): d 7.78 (d, J = 7.3 Hz, 2H), 7.26 (d, J = 7.3 Hz, 2H), 6.02 (bs, 1H), 
4.17 (t, J = 6.8 Hz, 1H), 2.48 (s, 3H), 1.78 (ddd, J = 7.5, 7.0, 6.4 Hz, 2H), 1.42-1.25 (m, 
4H), 0.75 (t, J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 144.3, 135.8, 129.8, 127.0, 
117.5, 44.1, 33.1, 26.8, 21.5, 21.4, 13.4 ppm. ESI-MS m/z (rel int): (pos) 267.1 ([M+H]+, 
100); (neg) 265.1 ([M−H]-, 100). 
 
 
N-(1-cyanobutyl)-4‐methylbenzenesulfonamide (2c): Sulfonylamidonitrile 2c was 
obtained (22 mg, 90%) as a colorless oil. TLC: Rf 0.64 (2:1 heptanes/EtOAc). 1H NMR 
(400 MHz, CDCl3): d 7.81 (d, J = 7.2 Hz, 2H), 7.28 (d, J = 7.2 Hz, 2H), 5.78 (bs, 1H), 
4.20 (bs, 1H), 2.48 (s, 3H), 1.78 (dt, J = 7.3, 6.9 Hz, 2H), 1.52-1.49 (m, 2H), 0.98 (t, J = 
6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 144.6, 135.9, 130.0, 127.2, 117.5, 44.1, 
35.9, 21.6, 18.4, 13.0 ppm. ESI‐MS m/z (rel int): (pos) 253.2 ([M+H]+, 100); (neg) 
251.2 ([M−H]-, 100). 
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N-(1-cyano-2‐methylpropyl)-4-methylbenzenesulfonamide (2d): Sulfonylamidonitrile 
2d was obtained (25 mg, 99%) as a pale‐yellow oil. TLC: Rf 0.64 (2:1 heptanes/EtOAc). 
1H NMR (400 MHz, CDCl3): d 7.75 (d, J = 7.1 Hz, 2H), 7.29 (d, J = 7.1 Hz, 2H), 5.58 (d, 
J = 5.7 Hz, 1H), 4.02 (d, J = 6.2 Hz, 1H), 2.48 (s, 3H), 1.78 (sd, J = 7.3, 6.8 Hz, 1H), 1.03 
(d, J = 7.3 Hz, 3H), 1.01 (d, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 144.3, 135.9, 
129.9, 127.0, 116.6, 50.5, 32.2, 21.5, 18.3, 17.6 ppm. ESI-MS m/z (rel int): (pos) 253.2 
([M+H]+, 100); (neg) 251.2 ([M‐H]-, 100). 
 
 
N‐(1‐cyano‐3‐phenylpropyl)‐4-methylbenzenesulfonamide (2e): 
Sulfonylamidonitrile 2e was obtained (29 mg, 92%) as a pale‐yellow oil.  TLC: Rf 0.68 
(2:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3): d 7.76 (d, J = 7.3 Hz, 2H), 7.28-
7.24 (m, 5H), 7.09 (d, J = 7.3 Hz, 2H), 6.11 (bs, 1H), 4.22 (t, J = 7.1 Hz, 1H), 2.77 (t, J = 
6.6 Hz, 2H), 2.48 (s, 3H), 2.06 (tt, J = 7.1, 6.6 Hz, 2H). 13C NMR (100 MHz, CDCl3): d 
144.3, 138.7, 135.6, 129.8, 128.5, 128.1, 127.0, 126.4, 117.3, 43.4, 34.9, 30.8, 21.3 ppm. 
ESI-MS m/z (rel int): (pos) 315.1 ([M+H]+, 100); (neg) 313.1 ([M‐H]-, 100). 
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N-(cyano(phenyl)methyl)-4‐methylbenzenesulfonamide (2f): 
Sulfonylamidonitrile 2f was obtained (25 mg, 89%) as a colorless oil. TLC: Rf 0.60 (2:1 
heptanes/EtOAc). 1H‐NMR (400 MHz, CDCl3): d 7.72 (d, J = 7.1 Hz, 2H), 7.25-7.22 
(m, 5H), 7.01 (d, J = 7.1 Hz, 2H), 6.28 (bs, 1H), 4.28 (s, 1H), 2.48 (s, 3H). 13C NMR 
(100 MHz, CDCl3): d 144.7, 139.1, 135.2, 129.6, 128.3, 128.0, 127.5, 126.3, 116.0, 43.4, 
21.3 ppm. ESI‐MS m/z (rel int): (pos) 287.2 ([M+H]+, 100); (neg) 285.2 ([M-H]-, 100). 
 
 
 
N-(cyano(p-tolyl)methyl)-4-methylbenzenesulfonamide (2): Sulfonylamidonitrile was 
obtained (29 mg, 97%) as a pale-yellow oil.  TLC: Rf 0.62 (2:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3): d 7.76 (d, J = 7.1 Hz, 2H), 7.29 (d, J = 7.2 Hz, 2H), 7.25 (d, J 
= 7.2 Hz, 2H), 7.19 (d, J = 7.1 Hz, 2H), 5.43 (s, 1H), 2.48 (s, 3H), 2.28 (s, 3H). 13C NMR 
(100 MHz, CDCl3): d 144.5, 139.9, 136.0, 130.0, 129.6, 129.1, 127.3, 127.0, 116.5, 47.9, 
21.6, 21.1 ppm. ESI-MS m/z (rel int): (pos) 301.1 ([M+H]+, 100); (neg) 299.1 ([M‐H]-, 
100). 
17 
 
 
N-(cyano(4‐methoxyphenyl)methyl)-4-methylbenzenesulfonamide (2g): Purification 
by automated silica gel flash chromatography (10 g cartridge, 12 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded sulfonylamidonitrile 2g (29 
mg, 91%) as a white solid. TLC: Rf 0.42 (2:1 heptanes/EtOAc). 1H NMR (400 MHz, 
CDCl3): d 7.76 (d, J = 7.1 Hz, 2H), 7.34‐7.32 (m, 4H), 7.28 (d, J = 7.1 Hz, 2H), 5.32 (s, 
1H), 3.76 (s, 3H), 2.48 (s, 3H). 13C NMR (100 MHz, CDCl3): d 160.4, 144.5, 135.9, 129.9, 
128.5, 127.2, 124.0, 116.5, 114.5, 55.3, 47.6, 21.6 ppm. ESI-MS m/z (rel int): (pos) 317.2 
([M+H]+, 100); (neg) 315.2 ([M-H]-, 100). 
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N‐(cyano(naphthalen-2-yl)methyl)-4-methylbenzenesulfonamide (2h): 
Sulfonylamidonitrile 2h was obtained (28 mg, 85%) as a colorless oil. TLC: Rf 0.55 (2:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3): d 7.99 (d, J = 7.1 Hz, 1H), 7.81 (d, J = 
7.2 Hz, 2H), 7.76 (d, J = 7.2 Hz, 2H), 7.67 (d, J = 7.1 Hz, 1H), 7.54 (t, J = 7.1 Hz, 2H), 
7.29 (t, J = 7.2 Hz, 1H), 7.23 (d, J = 7.2 Hz, 2H), 6.02 (bs, 1H), 5.49 (bs, 1H), 2.46 (s, 
3H). 13C NMR (100 MHz, CDCl3): d 144.6, 135.6, 133.9, 131.1, 129.9, 129.0, 127.8, 
127.3, 126.9, 126.6, 126.5, 124.9, 122.3, 116.4, 46.3, 21.6 ppm. ESI-MS m/z (rel int): 
(pos) 337.2 ([M+H]+, 100); (neg) 335.2 ([M‐H]-, 100).
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N-(benzo[d][1,3]dioxol-5-yl(cyano)methyl)-4-methylbenzenesulfonamide (2i): 
Sulfonylamidonitrile 2i was obtained (30 mg, 90%) as a pale-yellow oil. TLC: Rf 0.35 
(2:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3): d 7.74 (d, J = 7.1 Hz, 2H), 7.43 (d, 
J = 7.1 Hz, 2H), 7.21 (s, 1H), 6.97 (d, J = 7.3 Hz, 1H), 6.73 (d, J = 7.3 Hz, 1H), 5.82 (s, 
2H), 5.34 (s, 1H), 2.48 (s, 3H). 13C NMR (100 MHz, CDCl3): d 149.2, 146.3, 142.5, 
141.0, 128.7, 128.3, 126.5, 121.4, 118.6, 110.8, 107.8, 101.6, 54.7, 22.6 ppm. ESI-MS 
m/z (rel int): (pos) 331.1 ([M+H]+, 100); (neg) 329.1 ([M-H]-, 100).
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N-((4-chlorophenyl)(cyano)methyl)-4-methylbenzenesulfonamide (2j): Purification by 
automated silica gel flash chromatography (10 g cartridge, 12 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded sulfonylamidonitrile 2j (24 
mg, 75%) as a colorless oil. TLC: Rf 0.69 (2:1 heptanes/EtOAc). 1H NMR (400 MHz, 
CDCl3): d 7.76 (d, J = 7.3 Hz, 2H), 7.36-7.33 (m, 6H), 5.75 (bs, 1H), 5.45 (s, 1H), 2.48 (s, 
3H). 13C NMR (100 MHz, CDCl3): d 140.8, 135.9, 135.7, 130.6, 130.0, 129.5, 128.4, 
127.2, 116.0, 47.5, 21.6 ppm. ESI-MS m/z (rel int) (pos) 321.1 ([M+H]+, 100); (neg) 319.1 
([M−H]-, 100). 
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N-(cyano(4-nitrophenyl)methyl)-4-methylbenzenesulfonamide (2k): Purification by 
automated silica gel flash chromatography (10 g cartridge, 12 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded sulfonylamidonitrile 2k (26 
mg, 80%) as a white solid. TLC: Rf 0.58 (2:1 heptanes/EtOAc). 1H NMR (400 MHz, 
CDCl3): d 8.24 (d, J = 7.0 Hz, 2H), 7.78 (d, J = 7.0 Hz, 2H), 7.19 (d, J = 7.0 Hz, 2H), 7.49 
(d, J = 7.0 Hz, 2H), 5.34 (s, 1H), 2.48 (s, 3H). 13C NMR (100 MHz, CDCl3): d 148.5, 
142.1, 141.2, 138.4, 129.6, 128.1, 118.0, 54.1, 22.6 ppm. ESI-MS m/z (rel int): (pos) 332.2 
([M+H]+, 100); (neg) 330.2 ([M−H]-, 100). 
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 1.4.3. Synthesis of Sulfonylamidonitriles from Table 3. 
 
 
N-(1‐cyano-3-phenylpropyl)methanesulfonamide (2l): Purification by automated silica 
gel flash chromatography (10 g cartridge, 12 ml/min. 20:1 heptanes/EtOAc to 1:4 
heptanes/EtOAc over 12 min) yielded indole 2l (22 mg, 92%) as a colorless oil. TLC: Rf 
0.51 (2:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3): d 7.28-7.20 (m, 5H), 5.61 (bs, 
1H), 4.26 (t, J = 7.1 Hz, 1H), 3.05 (s, 3H), 2.79 (t, J = 6.6 Hz, 2H), 2.17 (tt, J = 7.1, 6.6 
Hz, 2H). 13C NMR (100 MHz, CDCl3): d 138.6, 128.8, 128.4, 126.8, 118.2, 43.8, 41.3, 
35.0, 31.1 ppm. ESI-MS m/z (rel int): (pos) 239.1 ([M+H]+, 100); (neg) 237.1 ([M-H]-, 
100). 
 
 
N-(1-cyano‐3-phenylpropyl)thiophene‐2-sulfonamide  (2m) Sulfonylamidonitrile 
2m was obtained (27 mg, 90%) as a pale-yellow oil. TLC: Rf 0.40 (2:1 heptanes/EtOAc). 
1H NMR (400 MHz, CDCl3): d 7.65 (d, J = 7.3 Hz, 2H), 7.28‐7.16 (m, 6H), 4.26 (t, J = 
6.5 Hz, 1H), 2.75 (t, J = 6.2 Hz, 2H), 2.15 (tt, J = 6.6, 6.2 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): d 138.6, 133.6, 133.4, 128.9, 128.4, 127.8, 126.8, 117.0, 44.0, 35.4, 31.1 ppm. 
ESI‐MS m/z (rel int): (pos) 307.2 ([M+H]+, 100); (neg) 305.2 ([M‐H]-, 100). 
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N-(1-cyano‐3-phenylpropyl)-4-nitrobenzenesulfonamide  (2n):  Sulfonylamidonitrile  
2n  was obtained (33 mg, 97%) as a white solid. TLC: Rf 0.57 (2:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3): d 8.35 (d, J = 7.1 Hz, 2H), 8.04 (d, J = 7.1 Hz, 2H), 7.28-7.16 
(m, 5H), 4.22 (t, J = 6.4 Hz, 1H), 2.79 (t, J = 6.6 Hz, 2H), 2.20 (tt, J = 6.9, 6.4 Hz, 2H), 
1.27 (bs, 1H). 13C NMR (100 MHz, CDCl3): d 150.4, 144.5, 138.3, 128.9, 128.8, 128.5, 
128.4, 128.3, 127.0, 124.6, 116.9, 43.8, 35.1, 31.0 ppm. ESI‐MS m/z (rel int): (pos) 
346.2 ([M+H]+, 100); (neg) 344.2 ([M-H]-, 100).
 
 
N-(1-cyano‐3-phenylpropyl)trifluoromethanesulfonamide (2o): Sulfonylamidonitrile 
2o was obtained (26 mg, 91%) as a pale-yellow oil. TLC: Rf 0.58 (2:1 heptanes/EtOAc). 
1H NMR (400 MHz, CDCl3): d 7.32-7.27 (m, 5H), 4.42 (t, J = 6.8 Hz, 1H), 2.77 (t, J = 
6.6 Hz, 2H), 2.24 (tt, J = 6.9, 6.5 Hz, 2H). 13C NMR (100 MHz, CDCl3): d 138.0, 128.9, 
128.4, 127.1, 126.6, 120.8 (q, J = 250 Hz, CF3), 116.6, 45.0, 35.6, 31.0 ppm. ESI-MS 
m/z (rel int): (pos) 293.1 ([M+H]+, 100); (neg) 291.1 ([M‐H]-, 100). 
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N-(cyano(4-methoxyphenyl)methyl)-4-nitrobenzenesulfonamide (2q): Purification by 
automated silica gel flash chromatography (10 g cartridge, 12 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded sulfonylamidonitrile 2q (30 
mg, 86%) as a white solid. TLC: Rf 0.40 (2:1 heptanes/EtOAc). 1H NMR (400 MHz, 
CDCl3): d 8.42 (d, J = 7.3 Hz, 2H), 8.08 (d, J = 7.3 Hz, 2H), 7.28 (d, J = 7.1 Hz, 2H), 6.88 
(d, J = 7.1 Hz, 2H), 5.52 (s, 1H), 3.78 (s, 3H). 13C NMR (100 MHz, CDCl3): d 160.9, 
150.2, 144.9, 128.7, 128.6, 128.3, 124.6, 123.1, 116.0, 114.5, 55.4, 47.9 ppm. ESI-MS m/z 
(rel int): (pos) 348.2 ([M+H]+, 100); (neg) 346.2 ([M-H]-, 100). 
 
 
N-(cyano(p-tolyl)methyl)thiophene-2-sulfonamide (2r): Sulfonylamidonitrile 2r was 
obtained (26 mg, 90%) as a pale-yellow oil. TLC: Rf 0.45 (2:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3): d 7.70 (d, J = 8.8 Hz, 2H), 7.29 (d, J = 7.1 Hz, 2H), 7.21 (d, J 
= 7.1 Hz, 2H), 7.16 (d, J = 8.8 Hz, 1H), 5.50 (s, 1H), 5.41 (s, 1H), 2.35 (s, 3H). 13C NMR 
(100 MHz, CDCl3): d 140.1, 139.8, 133.6, 133.4, 130.0, 128.7, 127.8, 127.0, 116.2, 48.1, 
21.1 ppm. ESI-MS m/z (rel int): (pos) 293.1 ([M+H]+, 100); (neg) 291.1 ([M-H]-, 100). 
 
25 
 
 
N-(1-cyanobutyl)-4-nitrobenzenesulfonamide (2s): Sulfonylamidonitrile 2s was 
obtained (26 mg, 93%) as a pale‐yellow oil. TLC: Rf 0.62 (2:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3): d 8.42 (d, J = 7.1 Hz, 2H), 8.08 (d, J = 7.1 Hz, 2H), 4.26 (t, J 
= 6.2 Hz, 1H), 1.76 (dt, J = 7.3, 6.9 Hz, 2H), 1.54-1.50 (m, 2H), 0.99 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): d 150.4, 144.8, 
26 
130.6, 128.6, 124.6, 117.2, 44.3, 35.6, 18.4, 13.0 ppm. ESI-MS m/z (rel int): (pos) 284.1 
([M+H]+, 100); (neg) 282.1 ([M-H]-, 100). 
 
 
N-(1-cyanooctyl)-4-nitrobenzenesulfonamide (2t): Sulfonylamidonitrile 2t was 
obtained (31 mg, 90%) as a pale‐yellow oil. TLC: Rf 0.66 (2:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3): d 8.48 (d, J = 7.3 Hz, 2H), 8.12 (d, J = 7.1 Hz, 2H), 4.26 (t, J 
= 6.4 Hz, 1H), 1.80 (dt, J = 7.3, 6.9 Hz, 2H), 1.52-1.48 (m, 2H), 1.32‐1.25 (m, 8H), 0.84 
(t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 150.4, 144.8, 128.5, 124.6, 117.2, 
44.5, 33.7, 31.5, 28.8, 28.8, 25.0, 22.5, 14.0 ppm. ESI-MS m/z (rel int): (pos) 340.1 
([M+H]+, 100); (neg) 338.1 ([M-H]-, 100). 
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 1.4.4. 1H NMR and 13C NMR of Sulfonylamidonitriles.
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Chapter 2 
 
Nitriles 
 
2.1 Introduction to the Synthesis of Nitriles 
Nitriles (Figure 5) are seen as key molecular scaffolds in organic chemistry and 
are used for the preparation of other functional groups, dyes, materials, and natural 
products.38 Nitriles have also been seen as a reoccurring pharmacophore in some 
commercially available drugs causing a need for a more efficient method of their 
synthesis to be developed.39-52 
 
 
 
 
Figure 5. General Structure of a Nitrile 
 
 
 
Most synthesis of nitriles rely on the displacement of a good leaving group by 
toxic cyanide sources such as potassium cyanide (KCN) and copper cyanide (CuCN).53-60 
One method that uses CuCN relies on a three-step process to achieve the desired nitrile. 
In this method an aromatic primary amine is added with sulfuric acid at 0˚C. After 
stirring for 30 minutes sodium nitrite is dissolved in water and added to the reaction still 
at 0˚C. This reaction mixture was then filtered, and the filtrate was combined with 
sodium carbonate, copper cyanide, and sodium cyanide in water. This method requires 
harsh reagents that are then separated, filtered, and washed with hot water. Other methods 
for the synthesis of these molecules involve the dehydration of amides and oximes under 
high temperature or harsh reagents.61-65 An example of these harsh reagents is a Uranium 
catalyzed reaction using N-methyl-N-(trimethylsiyl)trifluoroacetamide (MSTFA) as a 
dehydration reagent. In the presence of 3 equivalence of MSTFA and 5 mol percent 
UO2(NO3)2 hexahydrate in toluene at 100˚C excellent chemoselectivity and yield were 
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observed. Without these two reagents the reaction to the nitrile is not observed. 
Diminishing the amount of MSTFA produced lower yields while lowering the 
temperature had the same result. These methods generally suffer in poor substrate scope, 
difficulty of purifications, low yields, toxicity of reagents, generation of large amounts of 
organic waste, and use of expensive and sensitive catalysts.66-71 Through a variety of 
different labs it has been shown that Cu(II) and TEMPO with NH4OAc and Ag 
nanoparticles with K4Fe(CN)6 effectively promote the formation of nitriles from 
aldehydes72-74 while, O-(4-CF3-benzoyl)-hydroxylamine and CSA being used as an 
organic catalyst have been shown to promote the same reaction with a larger scope.75, 76 
Due to these factors a metal free, general synthesis method for nitriles from aldehydes 
was in need of development.77 
 
2.2 Nitrile Discovery 
Early work in the Moura-Letts research group was able to highlight the 
diastereoselective synthesis of diaziridines using Hydroxylamine O-Sulfonic Acid 
(HOSA) as the source of nitrogen from ketones and aldehydes.78 When optimizing this 
reaction, the researchers discovered a competing pathway that was analyzed and found 
to be a nitrile. After optimization this competing nitrile pathway led to obtaining nitriles 
in good to excellent yields with high chemoselectivity.  
 
 
 
 
Figure 6. Discovery of Competing Nitrile Pathway 
 
 
 
  The competition between these two pathways comes from the initial condensation 
step which allows for both products to be formed (Figure 6). The heterocyclic diaziridine 
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is formed from the initial condensation of the aldehyde and aniline. Whereas the nitrile 
condensation requires an initial Aldehyde-HOSA condensation.  
 After optimization of both pathways it becomes clear that the reaction media is 
the cause for forming the desired chemoselectivity of the desire products (Figure 7). 
 
 
 
 
Figure 7. Exploiting Heterogeneous Composition to Control Reaction 
 
 
 
 By using polar organic solvent (Figure 7A), the diaziridine is obtained in good to 
excellent yields. This reaction media promotes the condensation of the aldehyde and aniline 
through a heterogeneous reaction mixture. The inorganic HOSA is slowly introduced to 
the reaction which allows for the aldehyde-aniline condensation which prompts the 
diaziridine formation. Using aqueous media promotes the nitrile pathway allowing for the 
aldehyde-HOSA condensation to take place (Figure 7B). 
 
2.3 Results and Discussion 
The Optimization studies looked at a large range of organic solvents, additives, and 
temperature to determine the best conditions for this reaction to proceed accordingly. It 
was found that the reaction yield was increased significantly by increasing the 
stoichiometric ratio of hydroxylamine to aldehyde. By increasing this ratio to 2:1 the yield 
for the reaction was 45% (Table 5, Entry 1). Upon further testing it was found that the 
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molar equivalence of hydroxylamine could be lowered while not affecting the yield of the 
reaction while under thermal conditions (Table 5, Entry 6).  
A large array of solvents were used to better understand this reaction including 
several ionic liquids (Table 5, Entry 14-17). Despite this large array of solvents, the best 
results were found to be in aqueous medium with water as the solvent (Table 5, Entry 18-
22). Upon mild heating and an exogenous acid (1 molar equivalent, acetic acid) the reaction 
was found to produce the nitrile in excellent yields (Table 5, Entry 19). Upon discovering 
the optimal conditions for this reaction, we sought to determine the scope by looking into 
the effects of different functional groups on the aldehyde. 
 
 
 
Table 5 
Nitrile Synthesis Optimization Studies 
Entry Solvent Additiveb YieldcStoichiometrya
1:2
1:1.5 CHCl3
Temperature
none
none
rt 45%
rt 44%
1:1.5 [TMG][LA] 50 oC 53%none
1:1.5 [TMG][LA] 50 oC 84%TFA
1:1.5 [TMGPS][TFA] 50 oC 80%none
1
2
14
15
16
a. Aldehyde:NH2OSO3H. b.1 equiv. of additive. c. Isolated yields.
CHCl3
1:1.5 [TMGPS][TFA] 50 oC 82%H2O17
H
O N
conditions
1:1.5
CHCl3
ClCH2CH2Cl
none
none
none
40 oC 48%
50 oC 64%
60 oC 58%
5
6
7
CHCl3
1:1.5
1:1.5
1:1.5
ClCH2CH2Cl
ACN
none
none
none
80 oC 60%
50 oC 58%
50 oC 60%
8
9
10
H2O
1:1.5
1:1.5
1:1.5 DMSO none 50 oC 40%11
1:1.5 ClCH2CH2Cl 50
oC 75%12
ClCH2CH2Cl 50
oC 79%
50 oC 91%
13
18 H2O
1:1.5
1:1.5
PTSA
TFA
TFA
50 oC 95%19 H2O1:1.5 acetic acid
50 oC 94%20 Vinegar1:1.5 none
NH2OSO3H
1:1.5
1:1.5 ACN
none
none
rt 38%
rt 25%
3
4
H2O
50 oC 93%21 H2O1:1.25 acetic acid
50 oC 94%22 H2O1:1.1 acetic acid
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 Aliphatic aldehydes reacted to the nitrile in good to excellent yields under the 
optimized reaction conditions (Table 6, Entry 1-6). The alpha-beta unsaturated aldehydes 
also reacted to the nitrile in good to excellent yields (Table 6, Entry 8-11). In some cases, 
trace impurities were detected by proton NMR and were purified by standard silica gel 
column to isolate the product (Table 6, Entry 9).  
 
 
 
Table 6 
Aliphatic and Alpha-beta unsaturated Nitrile Synthesis Scope 
 
 
 
 
 Similar to the nitriles in Table 6 the aromatic aldehydes under the optimized 
reaction conditions afforded good to excellent yields. Different functionalization was 
added to the benzene ring, such as, electron withdrawing groups (Table 7, Entry 14-15). 
These groups showed a slight decrease in percent yield but upon further stirring for 16 hrs. 
instead of the standard 6 hrs. the reaction went to completion.  The aromatic nitriles along 
with the aliphatic and alpha-beta unsaturated nitriles all were obtained in high purity with 
no purification required except for one compound (Table 7, Entry 14). 
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Table 7 
Aromatic Nitrile Synthesis Scope 
 
 
 
 
 There are two proposed mechanisms for this reaction (Figure 8). Mechanism A 
involves a condensation to get the sulfonylimine. The oxygen attached to nitrogen attacks 
a proton which then allows water to attack the imine hydrogen and kick off the sulfonyl 
group allowing for the formation of the nitrile. Mechanism B also starts with a 
condensation to the sulfonylimine but then performs a syn-elimination to form the nitrile.  
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Figure 8. Proposed Mechanism for the Synthesis of Nitriles 
 
 
 
2.4 Conclusion 
This method provides a robust and versatile way to access the nitrile functional group 
in good to excellent yields. The scope of this method extends to aromatic, conjugated, and 
aliphatic aldehydes without the need for purification. Substitution along the aromatic ring 
does not have any effect on the efficiency of the reaction. The mild conditions of this 
reaction also allow for the incorporation of a variety of functional groups. The mechanisms 
proposed for this reaction rely on an elimination step to form the nitrile instead of going 
through an oxime or amide formation. 
 
2.5 Experimental 
Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar and 
used without further purification. Solvents were obtained from EMD Miliphore DrySol 
and degassed with nitrogen. Reactions were performed in 4- mL glass vials with magnetic 
stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized 
under UV light (254 nm) or by staining with potassium permanganate (KMnO4). Silica 
flash chromatography was performed on E. Merck 230-400 mesh silica gel 60. Automated 
chromatography was performed on an ISOLERA Prime instrument with 10 g. SNAP silica 
gel normal phase cartridges using a flow rate of 12.0 mL/min and a gradient of 0- 30% 
EtOAc in Heptanes over 12 column volumes with UV detection at 254 nm. NMR spectra 
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were recorded on Varian Mercury II 400 MHz Spectrometer at 9 24 °C in CDCl3 unless 
otherwise indicated. Chemical shifts are expressed in ppm relative to solvent signals: 
CDCl3 (
1H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed in Hz. 
 
2.5.1. General method for the synthesis of Nitriles. In a 4-mL reaction vial, 
aldehyde (1.0 mmol, 1.0 equiv) and HOSA (1.1 mmol, 1.1 equiv.) were dissolved in 3 mL 
of de-ionized H2O with (1 mmol, 1 equiv) acetic acid. The solution was stirred at 50 °C for 
6 h or until complete conversion, determined by TLC. The reaction was quenched with 
aqueous 10% NaHCO3 (1 mL) and the resulting mixture was extracted with EtOAc (3 x 10 
mL), dried (Na2SO4), filtered, and concentrated by rotary evaporation to afford the crude 
product. The product was directly characterized unless traces of impurities required 
purification by automated silica gel flash chromatography (few examples). 
 
2.5.2. Synthesis of Nitriles from Table 6. 
 
 
3-Phenylpropanenitrile (T2A): Aldehyde (100mg, 0.75mMol) produced nitrile 2a 
(93mg, 95%) as a clear oil. TLC: Rf 0.47 (3:1 Heptanes/EtOAc). IR (thin film) 2250 cm
-1. 
1H-NMR (400 MHz, CDCl3): 7.38-7.29 (m, 5H), 2.99 (t, J = 7.3 Hz, 2H), 2.64 (t, J= 7.3Hz, 
2H). 13C-NMR (100MHz, CDCl3): 138.0, 128.8, 128.2, 127.1, 119.1, 31.4, 19.2 ppm. ESI-
MS m/z (re lint): (pos) 132.1 ([M+H]+, 100); (neg) 130.1 ([M-H]-,100). 
 
 
 
2-Phenylacetonitrile (T2B): Aldehyde (100mg, 0.83mMol) produced nitrile 2b (89mg, 
92%) as a clear oil. TLC: Rf 0.48 (3:1 Heptanes/EtOAc). IR (thin film) 2255 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.43-7.38 (m, 5H), 3.76 (s, 2H). 13C-NMR (100MHz, CDCl3) 
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129.8, 128.9, 127.8, 127.8, 117.8, 23.4 ppm. ESI-MS m/z (re lint): (pos) 118.1 ([M+H]+, 
100); (neg) 116.1 ([M-H]-,100). 
 
 
 
3-(4-Isopropylphenyl)-2-methylpropanenitrile (T2C): Aldehyde (100mg, 0.53 mMol) 
produced nitrile 2c (93mg, 94%) as a clear oil. TLC: Rf 0.68 (3:1 Heptanes/EtOAc). IR 
(thin film) 2290 cm-1. 1H-NMR (400 MHz, CDCl3): 7.23 (q, J = 6.8 Hz, 4H), 2.91-2.73 
(m, 4H), 1.31 (d, J = 6.8 Hz, 3H), 1.23 (d, J = 6.8 Hz, 6H). 13C-NMR (100MHz, CDCl3) 
147.8, 134.1, 128.9, 126.7, 122.7, 39.6, 33.7, 27.6, 23.9, 17.6 ppm. ESI-MS m/z (re lint): 
(pos) 188.1 ([M+H]+, 100); (neg) 186.1 ([M-H]-,100). 
 
 
Octanenitrile (T2D): Aldehyde (100mg, 1.16 mMol) produced nitrile 2e (85 mg, 88%) as 
a light-yellow oil. TLC: Rf 0.58 (3:1 Heptanes/EtOAc). IR (thin film) 2240 cm
-1. 1H-NMR 
(400 MHz, CDCl3): 2.28 (t, J = 7.1 Hz, 2H), 1.65 (quintet, J = 6.9 Hz, 2H), 1.47 (sextet, J 
= 6.9 Hz, 2H), 0.88 (t, J = 6.9 Hz, 3H). 13C-NMR (100MHz, CDCl3) 119.7, 26.6, 22.0, 
16.7, 13.1 ppm. ESI-MS m/z (re lint): (pos) 84.1 ([M+H]+, 100); (neg) 82.1 ([M-H]-,100). 
 
 
 
 
Pentanenitrile (T2E): Aldehyde (100mg, 1.16 mMol) produced nitrile 2e (85 mg, 88%) 
as a light-yellow oil. TLC: Rf 0.58 (3:1 Heptanes/EtOAc). IR (thin film) 2240 cm
-1. 1H-
NMR (400 MHz, CDCl3): 2.28 (t, J = 7.1 Hz, 2H), 1.65 (quintet, J = 6.9 Hz, 2H), 1.47 
(sextet, J = 6.9 Hz, 2H), 0.88 (t, J = 6.9 Hz, 3H). 13C-NMR (100MHz, CDCl3) 119.7, 26.6, 
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22.0, 16.7, 13.1 ppm. ESI-MS m/z (re lint): (pos) 84.1 ([M+H]+, 100); (neg) 82.1 ([M-H]-
,100). 
 
 
 
Glutaronitrile (T2F): Aldehyde (100mg, 1.03 mMol) produced nitrile 2f (83 mg, 86%) as 
a clear oil. TLC: Rf 0.71 (3:1 Heptanes/EtOAc). IR (thin film) 2250 cm
-1. 1H-NMR (400 
MHz, CDCl3): 2.51 (t, J = 7.3 Hz, 4H), 3.74 (quintet, J = 7.3 Hz, 2H). 13C-NMR (100MHz, 
CDCl3) 117.7, 21.6, 16.2 ppm. ESI-MS m/z (re lint): (pos) 95.1 ([M+H]+, 100); (neg) 93.1 
([M-H]-,100). 
 
 
 
Cinnamonitrile (T2G): Aldehyde (100mg, 0.76 mMol) produced nitrile 2g (83 mg, 89%) 
as a light-yellow oil. TLC: Rf 0.75 (3:1 Heptanes/EtOAc). IR (thin film) 2210 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.41-7.32 (m, 6H), 5.78 (d, J = 16.1 Hz, 1H). 13C-NMR 
(100MHz, CDCl3) 150.4, 133.3, 131.0, 128.9, 127.2, 118.0, 96.1 ppm. ESI-MS m/z (re 
lint): (pos) 130.1 ([M+H]+, 100); (neg) 128.1 ([M-H]-,100). 
 
 
(E)-3-(4-Methoxyphenyl)-acrylonitrile (T2H): Aldehyde (100mg, 0.62 mMol) produced 
nitrile 2h (86 mg, 87%) as a white solid. TLC: Rf 0.42 (3:1 Heptanes/EtOAc). IR (thin 
film) 2215 cm-1. 1H-NMR (400 MHz, CDCl3): 7.29 (d, J = 6.6 Hz, 2H), 7.25 (d, J = 16.5 
Hz, 1H), 6.93 (d, J = 6.6 Hz, 2H), 5.83 (d, J = 16.3 Hz, 1H), 3.89 (s, 3H). 13C-NMR 
(100MHz, CDCl3) 162.0, 150.0, 129.0, 126.3, 118.7, 114.5, 93.3, 55.4 ppm. ESI-MS m/z 
(re lint): (pos) 160.1 ([M+H]+ ,100); (neg) 158.1 ([M-H]-,100). 
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(E)-5-Methyl-2-phenylhex-2-enenitrile (T2I): Aldehyde (100mg, 0.53 mMol) produced 
nitrile 2i (84 mg, 86%) as a clear oil. TLC: Rf 0.69 (3:1 Heptanes/EtOAc). IR (thin film) 
2205 cm-1. 1H-NMR (400 MHz, CDCl3): 7.49-7.43 (m, 5H), 6.71 (t, J = 6.8 Hz, 1H), 2.25 
(dd, J = 7.5, 6.8 Hz, 2H), 1.79-1.75 (m, 1H), (d, J = 7.1 Hz, 6H). 13C-NMR (100MHz, 
CDCl3) 148.9, 136.4, 129.4, 128.8, 125.5, 116.2, 107.5, 37.5, 28.8, 22.4 ppm. ESI-MS m/z 
(re lint): (pos) 186.1 ([M+H]+, 100); (neg) 184.1 ([M-H]-,100). 
 
 
 
 
(E)-Hex-2-enenitrile (T2J): Aldehyde (100mg, 1.02 mMol) produced nitrile 2j (89 mg, 
92%) as a clear oil. TLC: Rf 0.66 (3:1 Heptanes/EtOAc). IR (thin film) 2210 cm
-1. 1H-
NMR (400 MHz, CDCl3): 6.91 (dt, J = 16.1, 7.1 Hz, 1H), 5.27 (d, J = 16.1Hz, 1H), 2.24 
(dt, J = 7.3, 7.1 Hz, 2H), 1.47 (sextet, J = 7.3 Hz, 2H), 0.82 (t, J = 6.9 Hz, 3H). 13C-NMR 
(100MHz, CDCl3) 155.8, 117.4, 99.6, 35.1, 20.8, 13.3 ppm. ESI-MS m/z (re lint): (pos) 
96.1 ([M+H]+, 100); (neg) 94.1 ([M-H]-,100). 
 
2.5.3. Synthesis of Nitriles from Table 7. 
 
4-Bromobenzonitrile (T3A): Aldehyde (100mg, 0.54 mMol) produced nitrile 3a (90mg, 
92%) as a white solid. TLC: Rf 0.70 (3:1 Heptanes/EtOAc). IR (thin film) 2215 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.62 (d, J = 7.1 Hz, 2H), 7.49 (d, J = 7.1 Hz, 2H). 13C-NMR 
(100MHz, CDCl3) 133.4, 132.6, 128.0, 118.0, 111.2 ppm. ESI-MS m/z (re lint): (pos) 
182.0 ([M+H]+, 100); (neg) 180.0 ([M-H]-,100). 
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4-Methylbenzonitrile (T3B): Aldehyde (100mg, 0.83 mMol) produced nitrile 3b (94mg, 
97%) as a clear oil. TLC: Rf 0.66 (3:1 Heptanes/EtOAc). IR (thin film) 2210 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.54 (d, J = 7.0 Hz, 2H), 7.27 (d, J = 7.1Hz, 2H), 2.44 (s, 3H). 
13C-NMR (100MHz, CDCl3) 143.6, 132.0, 129.8, 119.1, 109.2, 21.8 ppm. ESI-MS m/z 
(re lint): (pos) 118.1 ([M+H]+, 100); (neg) 116.1 ([M-H]-,100). 
 
 
 
 
4-Methoxybenzonitrile (T3C): Aldehyde (100mg, 0.74mMol) produced nitrile 3c (94mg, 
93%) as a white solid. TLC: Rf 0.44 (3:1 Heptanes/EtOAc). IR (thin film) 2210 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.52 (d, J = 7.3 Hz, 2H), 6.91 (d, J = 7.3 Hz, 2H), 3.78 (s, 3H). 
13C-NMR (100MHz, CDCl3) 162.8, 133.9, 119.2, 114.7, 103.9, 55.5 ppm. ESI-MS m/z 
(re lint): (pos) 134.1 ([M+H]+, 100); (neg) 132.1 ([M-H]-,100). 
 
 
 
Benzonitrile (T3D): Aldehyde (100mg, 0.94 mMol) produced nitrile 3d (92mg, 95%) as 
a clear liquid. TLC: Rf 0.68 (3:1 Heptanes/EtOAc). IR (thin film) 2220 cm
-1. 1H-NMR 
(400 MHz, CDCl3): 7.52-7.32 (m, 5H). 13C-NMR (100MHz, CDCl3) 132.3, 131.5, 128.6, 
118.3, 111.7 ppm. ESI-MS m/z (re lint): (pos) 104.1 ([M+H]+, 100); (neg) 102.1 ([M-H]-
,100). 
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4-Chlorobenzonitrile (T3E): Aldehyde (100mg, 0.71 mMol) produced nitrile 3e (91mg, 
94%) as a white solid. TLC: Rf 0.75 (3:1 Heptanes/EtOAc). IR (thin film) 2220 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.58 (d, J = 7.1 Hz, 2H), 7.47 (d, J = 7.1 Hz, 2H). 13C-NMR 
(100MHz, CDCl3) 139.5, 133.4, 129.7, 118.0, 110.7 ppm. ESI-MS m/z (re lint): (pos) 
138.0 ([M+H]+, 100); (neg) 136.0 ([M-H]-,100). 
 
 
 
 
Isonicotinonitrile (T3F): Aldehyde (100mg, 0.93 mMol) produced nitrile 3f (88mg, 91%) 
as a white solid. TLC: Rf 0.14 (3:1 Heptanes/EtOAc). IR (thin film) 2225 cm
-1. 1H-NMR 
(400 MHz, CDCl3): 8.53 (d, J = 6.8 Hz, 2H), 7.52 (d, J = 6.8 Hz, 2H). 13C-NMR (100MHz, 
CDCl3) 150.7, 125.2, 120.4, 116.3 ppm. ESI-MS m/z (re lint): (pos) 105.1 ([M+H]
+, 100); 
(neg) 103.1 ([M-H]-,100). 
 
 
 
3,4-Dichlorobenzonitrile (T3G): Aldehyde (100mg, 0.57 mMol) produced nitrile 3g 
(86mg, 89%) as a white solid. TLC: Rf 0.56 (3:1 Heptanes/EtOAc). IR (thin film) 2224 
cm-1. 1H-NMR (400 MHz, CDCl3): 7.63 (d, J = 6.6 Hz, 1H), 7.50 (s, 1H), 7.29 (d, J = 6.6 
Hz, 1H). 13C-NMR (100MHz, CDCl3) 140.0, 137.7, 134.5, 130.2, 127.8, 115.2, 111.8 ppm. 
ESI-MS m/z (re lint): (pos) 172.0 ([M+H]+, 100); (neg) 170.0 ([M-H]-,100). 
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3-Chlorobenzonitrile (T3H): Aldehyde (100mg, 0.71 mMol) produced nitrile 3h (87 mg, 
89%) as a white solid. TLC: Rf 0.54 (3:1 Heptanes/EtOAc). IR (thin film) 2225 cm
-1. 1H-
NMR (400 MHz, CDCl3): 7.63 (s, 1H), 7.58-7.51 (m, 2H), 7.41 (t, J = 6.9 Hz, 1H). 13C-
NMR (100MHz, CDCl3) 135.1, 133.1, 131.8, 130.4, 130.2, 117.3, 113.8 ppm. ESI-MS 
m/z (re lint): (pos) 138.0 ([M+H]+, 100); (neg) 136.0 ([M-H]-,100). 
 
. 
 
 
3,4-Dimethoxybenzonitrile (T3I): Aldehyde (100mg, 0.60 mMol) produced nitrile 3i (91 
mg, 93%) as a white solid. TLC: Rf 0.29 (3:1 Heptanes/EtOAc). IR (thin film) 2215 cm
-1. 
1H-NMR (400 MHz, CDCl3): 7.25 (d, J = 6.8 Hz, 1H), 7.03 (s, 1H), 6.82 (d, J = 6.8 Hz, 
1H), 3.92 (s, 3H), 3.87 (s, 3H). 13C-NMR (100MHz, CDCl3) 152.7, 149.1, 126.4, 119.1, 
113.8, 111.1, 103.8, 56.1, 56.0 ppm. ESI-MS m/z (re lint): (pos) 164.1 ([M+H]+, 100); 
(neg) 162.1 ([M-H]-,100). 
 
 
Benzo[d][1,3]dioxole-5-carbonitrile (T3J): Aldehyde (100mg, 0.67 mMol) produced 
nitrile 3j (96 mg, 97%) as a white solid. TLC: Rf 0.38 (3:1 Heptanes/EtOAc). IR (thin film) 
2210 cm-1. 1H-NMR (400 MHz, CDCl3): 7.21 ( d, J = 6.8 Hz, 1H), 6.99 (s, 1H), 6.77 (d, J 
= 6.8 Hz, 1H), 6.02 (s, 2H). 13C-NMR (100MHz, CDCl3) 151.5, 147.9, 128.1, 118.8, 111.3, 
109.0, 104.8, 102.2 ppm. ESI-MS m/z (re lint): (pos) 148.1 ([M+H]+, 100); (neg) 146.1 
([M-H]-,100). 
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4-Naphtonitrile (T3K): Aldehyde (100mg, 0.67 mMol) produced nitrile 3k (96 mg, 85%) 
as a tan solid. TLC: Rf 0.77 (3:1 Heptanes/EtOAc). IR (thin film) 2205 cm
-1. 1H-NMR 
(400 MHz, CDCl3): 8.19 (d, J = 6.6 Hz, 1H), 8.04 (d, J = 6.6 Hz, 1H), 7.87 (t, J = 6.9 Hz, 
2H), 7.65 (d, J = 6.8 Hz, 1H), 7.58 (d, J = 6.8 Hz, 1H), 7.47 (d, J = 6.8 Hz, 1H). 13C-NMR 
(100MHz, CDCl3) 133.2, 132.8, 132.5, 132.2, 128.6, 128.5, 127.4, 125.0, 124.8, 117.7, 
110.0 ppm. ESI-MS m/z (re lint): (pos) 154.1 ([M+H]+, 100); (neg) 152.1 ([M-H]-,100). 
 
 
OMe
HO
MeO
N  
4-Hydroxy-3,5-dimethoxybenzonitrile (T3L): Aldehyde (100mg, 0.55 mMol) produced 
nitrile 3l (96 mg, 98%) as a white solid. TLC: Rf 0.12 (3:1 Heptanes/EtOAc). IR (thin film) 
3450, 2240 cm-1. 1H-NMR (400 MHz, CDCl3): 6.82 (s, 2H), 3.87 (s, 6H). 13C-NMR 
(100MHz, CDCl3) 147.1, 139.2, 119.3, 109.1, 102.2, 56.5 ppm. ESI-MS m/z (re lint): (pos) 
180.1 ([M+H]+, 100); (neg) 178.1 ([M-H]-,100). 
 
 
 
3-Hydroxybenzonitirle (T3M): Aldehyde (100mg, 0.66mMol) produced nitrile 3n (84 
mg, 86%) as a light yellow solid. TLC: Rf 0.53 (3:1 Heptanes/EtOAc). IR (thin film) 2240 
cm-1. 1H-NMR (400 MHz, CDCl3): 8.33-8.31 (m, 1H), 7.92-7.89 (m, 1H), 7.84- 7.82 (m, 
2H). 13C-NMR (100MHz, CDCl3) 135.5, 134.3, 133.7, 125.5, 114.9, 108.0 ppm. ESI-MS 
m/z (re lint): (pos) 149.1 ([M+H]+, 100); (neg) 147.1 ([M-H]-,100). 
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2-Nitrobenzonitrile (T3N): Aldehyde (100mg, 0.66mMol) produced nitrile 3n (84 mg, 
86%) as a light yellow solid. TLC: Rf 0.53 (3:1 Heptanes/EtOAc). IR (thin film) 2240 cm
-
1. 1H-NMR (400 MHz, CDCl3): 8.33-8.31 (m, 1H), 7.92-7.89 (m, 1H), 7.84- 7.82 (m, 2H). 
13C-NMR (100MHz, CDCl3) 135.5, 134.3, 133.7, 125.5, 114.9, 108.0 ppm. ESI-MS m/z 
(re lint): (pos) 149.1 ([M+H]+, 100); (neg) 147.1 ([M-H]-,100). 
 
 
 
3-Nitrobenzonitrile (T3O): Aldehyde (100mg, 0.66 mMol) produced nitrile 3o (80 mg, 
82%) as a light yellow solid. TLC: Rf 0.55 (3:1 Heptanes/EtOAc). IR (thin film) 2235 cm
-
1. 1H-NMR (400 MHz, CDCl3): 8.51 (s, 1H), 8.44 (d, J = 6.6 Hz, 1H), 7.96 (d, J = 6.6 Hz, 
1H), 7.74 (dt, J = 6.6 Hz, 1H). 13C-NMR (100MHz, CDCl3) 137.6, 130.6, 127.5, 127.4, 
127.2, 116.5, 114.1 ppm. ESI-MS m/z (re lint): (pos) 149.1 ([M+H]+, 100); (neg) 147.1 
([M-H]-,100). 
 
 
2-Hydroxybenzonitrile (T3P): Aldehyde (100mg, 0.82 mMol) produced nitrile 3p 
(93mg, 95%) as a white solid. TLC: Rf 0.29 (3:1 Heptanes/EtOAc). IR (thin film) 3460, 
2250 cm-1. 1H-NMR (400 MHz, CDCl3): 7.52-7.44 (m, 2H), 7.39 (bs, 1H), 7.07 (d, J = 
7.1 Hz, 1H), 6.97 (t, J = 7.1 Hz, 1H). 13C-NMR (100MHz, CDCl3) 159.4, 135.3, 135.2, 
133.3, 120.9, 116.9, 99.3 ppm. ESI-MS m/z (re lint): (pos) 120.1 ([M+H]+, 100); (neg) 
118.1 ([M-H]-,100). 
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 2.5.4. 1H NMR and 13C NMR of Nitriles. 
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Chapter 3 
 
Nitrone Dipolar Cycloaddition 
 
3.1 Introduction to the Nitrone Dipolar Cycloaddition  
 Isoxazolidines (Figure 9) have been a relevant pharmaceutical scaffold for the last 
50 years and even appear in many commercially available drugs.79-83 This scaffold has also 
been found to have biological activity while also mimicking a wide range of natural 
building blocks.84-88 The synthesis of this scaffold has been an important part of organic 
chemistry for these reasons. 
 
 
 
 
Figure 9. General Structure of an Isoxazolidine 
 
 
 
 The most successful reaction for the synthesis of isoxazolidines has been the 1, 3-
dipolar cycloaddition of nitrones (Figure 10) with an α, β-unsaturated aldehyde.89-93 This 
reaction has a high energetic demand94 that is usually countered through Lewis acid 
catalysis that is able to enhance the conversion, scope, reaction rates, and the different types 
of selectivites such as regio-, enantio-, and diastero-.95-99 
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Figure 10. General Structure of a Nitrone 
 
 
 
 Previous research has shown that when a nitrone is reacted in the presences of an 
Fe or Ru Lewis acid catalyst produced the endo product of the [3+2] cycloaddition. This 
high preference for the endo product as seen by the Kündig group did not allow for an 
exo selective Ru catalyst to be used. The low solubility of nitrones also caused a different 
set of nitrones to be considered due to the long reaction times and the low stability of the 
Fe catalyst. Using a cyclic set of nitrones Kündig was able to use the Fe or Ru catalysts 
which led to excellents yields and moderate stereoselectivity. When compared it was seen 
that the Fe catalyst was better than the Ru catalyst in terms of selectivity due to the Fe 
catalyst having a larger catalyst site while, the Ru catalyst was a slightly weaker Lewis 
acid. 
 Even though these Lewis acid catalyzed reactions do enhance the regio- and 
diastereoselectivities there are no clear trends that allow for the prediction of these 
outcomes.100, 101 Some computational studies have shown that there exists an electronic 
bias for the 3, 5-isoxazolidine when carbonyls and cyano groups are on the dipolarophile. 
These studies have also shown that the 3, 4-isoxazolidine is favored with other electron 
withdrawing groups on the dipolarophile.102 Similar calculations show a clear preference 
for the endo product (Figure ) while, also predicting that thermal or Lewis acid promoted 
nitrone dipolar cycloadditions have similar regioselective tendencies.103-115 There are no 
reported efforts to rationalize these tendencies.  
 There are a variety of methods to obtain substituted nitrones for cycloadditions 
depends upon the added functionality of the nitrone.90, 116-122 Vinyl nitrones are a specific 
type of nitrone that allow for the synthesis of highly complex heterocycles. These nitrones 
73 
are synthesized through the condensation of conjugated carbonyls and hydroxylamines.123-
125 With these two substrates a highly functionalized isoxazolidine can be synthesized.126 
 
3.2 Pharmaceutical Relevance  
 Resistant antibiotic bacterial strains have resulted in a large demand for small 
molecule antibiotics. Beta Lactams have historically filled this rule since the advent of 
penicillin due to their powerful antibacterial properties. 
 
 
 
 
Figure 11. Enantioselective Synthesis of Beta Lactams 
 
 
 
 Using nitrones an enantioselective synthesis of beta lactams (Figure 11) has 
significant applications in the pharmaceutical industry.127 Even though lactams have been 
historically used for bacterial infection treatment, new structural motifs are becoming 
more required to fight bacterial evolution. One motif can be synthesized from the 
isoxazolidine scaffold. 
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Figure 12. Reductive Cleavage of N-O Bond to Afford Negamycin 
 
 
 
 Through reductive cleavage of the nitrogen-oxygen bond pharmaceutically 
relevant amino acids can be formed (Figure 12). With the conformation of the 
isoxazolidine preserved the total synthesis of the natural product, Negamycin can be 
achieved.128 This natural product has several functional groups that can be modified to 
produce novel antibacterial pharmaceuticals. 
 
3.3 Results and Discussion 
 With the importance of highly structured isoxazolidines, a library of 3-Vinyl-4-
Carbonyl-Isoxazolidines from conjugated carbonyls and simple hydroxylamines was 
synthesized. This synthesis followed the mechanism of a traditional [3+2] cycloaddition. 
 During optimization studies after acrolein (Table 8 -B) underwent a condensation 
with N-Benzylhydroxylamine, the resulting product underwent a dipolar cycloaddition 
with unreacted acrolein instead of the dipolarphile (Table 8 - A). This reaction led us to 
hypothesis the optimal enal - dipolarphile pair. This hypothesized pair made the reaction 
able to proceed as a one pot conversion without losing chemoselectivity. 
 Temperature was screened next to determine if the yield of the reaction would 
increase. It was found that increasing the temperature to 80˚C afforded the highest 
percent yield while going past this point reduced the diastereoselective of the reaction 
(Table 8, Entry 7 and 8). Decreasing the temperature did not help improve the 
diastereoselectivity and decreased the conversion to the desired cycloadduct (Table 8, 
Entry 6). 
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While trying to lower the energetic requirement for this reaction several Lewis 
acid metal catalysts were tested. The rates of the reaction were noticed to increase along 
with a modest increase in diasteroselectivity, while the percent yield of the reaction 
decreased (Table 8, Entry 12). The small increase in diasteroselectivity with the Lewis 
acid metal catalysts did not make up for the loss in percent yield and so thermal 
conditions remained the most optimal.  
 
 
 
Table 8 
3-Vinyl-4-Carbonyl-Isoxazolidine Reaction Optimization 
O +
O
BnNHOH
MeO
OMePh
N
Bn
O
O
Additive
Solvent
Additivee Time %Yield of C:D:E:FbEntrya Enal Dipolarophile
A B
C
B B none 48h
Temperature
rt 0:0:20:21
Bd A none 48h rt 5:1:10:22
B A none 48h rt 8:2:6:23
A B none 48h rt 40:4:0:04
A B none 48h 40 oC 53:6:0:05
A B none 16h 60 oC 64:9:0:06
A B none 16h 80 oC 88:4:0:07
A B 18h 90 oC 80:16:0:08
A B 16h 80:4:0:09
A B 16h 73:8:0:010
A B 16h 64:12:0:011
A B 6h rt 64:28:0:012
A B 6h rt 35:24:0:013
A B 6h rt 53:22:0:014
A B 6h rt 48:20:0:015
A B 6h rt 46:32:0:016
Cu(OTf)2
Cu(OAc)2
AgOTf
AuOTf
Fe(OTf)3
a. Ratio of enal:dipolarophile:hydroxylamine, 1:2:1. b. Isolated yields. c. Ratio for the major isomer,
measured by 1H-NMR. d. ratio of enal:dipolarophile is 1:1. e. Lewis acid were added in 20 mol%.
d.rc
8:1
8:1
6:1
10:1
15:1
15:1
15:1
10:1
15:1
15:1
15:1
20:1
20:1
20:1
15:1
15:1
D
E
N
Bn
O
O
F
OMePh
N
Bn
O
O
N
Bn
O
O
Solvent
none
none
none
none
DCE
DCE
DCE
DCE
DCE
DCE
DCE
DCE
dioxane
DCE
DCE
DCE
DCE
DCE
80 oC
80 oC
80 oC
Acetonitrile
DMF
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 With the optimal conditions we set out to determine the scope of this reaction. 
Cinnamaldehyde was reluctant to perform the cycloaddition as a dipolarphile so para-
methoxy cinnamaldehyde was used instead. This prevented any side cycloadditions as 
previously seen with cinnamaldehyde allowing the reaction to be a one pot reaction. 
Simple enals and enones were observed to be suitable dipolarphiles. Straight enal alkyl 
chains showed traces of regioexcess (Table 9, Entry 1-3), while enal alkyl chain 
branching afforded complete regioselectivity as observed in methacrolein (Table 9, Entry 
4). Similar regioselectivity was seen in both cyclic and acyclic ketones. This similarity 
did see a drop in diasteroselectivity (Table 9, Entry 4-7). 
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Table 9 
Dipolarphile Scope: Aldehydes and Ketones 
O
+ BnNHOH
N
Bn
O
O
MeO
MeO
Product %Yield of 3,4-VCI2 d.r.3Dipolarophile
O
OC3H7
O
N
Bn
O
O
MeO
C3H7
N
Bn
O
MeO
N
Bn
O
O
MeO
R
O
N
Bn
O
O
MeO
88
90
84
0
Entry1
1
2
3
4
O
O
O
N
Bn
O
MeO
N
Bn
O
MeO
N
Bn
O
MeO
0
0
0
5
6
7
1. Ratio of enal:dipolarophile:hydroxylamine, 1:2:1. 2. Isolated yields. 3. Ratio for the major isomer,
measured by 1H-NMR.
15:1
16:1
15:1
12:1
12:1
12:1
12:1
Dipolarophile
N
Bn
O
MeO
+
R
O
3-vinyl-4-formyl-isoxazolidine
3,4-VFI
3-vinyl-5-formyl-isoxazolidine
3,5-VFI
%Yield of 3,5-VCI2
4
2
4
91
90
92
73
O
O
Et
O
O
Dichloroethane, 0.5M
 
 
 
 
 The scope was expanded further by changing the functional group of the enal. 
Acrylonitrile was used as a dipolarphile and afforded the 3-Vinyl-4-Formyl-Isoxazolidine 
(Table 10, Entry 1). Bulkier esters were found to produce the 3-Vinyl-5-Formyl-
Isoxazolidine (Table 10, Entry 4 & 5).  
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Table 10 
Dipolarphile Scope: Nitriles and Esters 
N
O
O
O
O
O
O
BuO O
Bu
O
O
Et
O
OEt
N
Bn
O
MeO
N
N
Bn
O
MeO
N
Bn
O
MeO
N
Bn
O
MeO
O
O
O
O
Bu
Bu
N
Bn
O
MeO
O
O
O
O
Et
Et
95
0
0
88
89
O + BnNHOH
MeO
Product d.r.3DipolarophileEntry
1
1
2
3
4
5
1. Ratio of enal:dipolarophile:hydroxylamine, 1:2:1. 2. Isolated yields. 3. Measured by 1H-NMR.
Dichloroethane, 0.5M
15:1
16:1
15:1
18:1
18:1
Dipolarophile
N
Bn
O
O
MeO
R
N
Bn
O
MeO
+
R
O
3-vinyl-4-formyl-isoxazolidine
3,4-VFI
3-vinyl-5-formyl-isoxazolidine
3,5-VFI
%Yield of 3,4-VFI2 %Yield of 3,5-VFI2
0
91
84
O
OtBu
O
OMe
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Table 11 
Dipole Scope 
+ BnNHOH
Product d.r.3EnalEntry1
1
2
3
4
5
1. Ratio of enal:dipolarophile:hydroxylamine, 1:2:1. 2. Isolated yields. 3. Measured by 1H-NMR.
Dichloroethane, 0.5M
15:1
16:1
15:1
12:1
12:1
N
Bn
O
O
N
Bn
OO
Me2N
Me2N
N
Bn
O
O
O
N
Bn
OC3H7
O
N
Bn
O
0
0
0
0
0
Ph
N
Bn
O
O
OR
O
Bn
ON
06 14:1
3-vinylhexahydro
benzoisoxazol-7-one
3,7-VBI
O
Ph
N
Bn
O
O
3-vinylhexahydro
benzoisoxazol-4-one
3,4-VBI
+
% of 3,4-VBI2 % of 3,7-VBI2
O
O
O
O
O
O
73
79
88
84
86
80
 
 
 
 
3.4 Conclusion 
 This method shows the regioselectivity of conjugated dipolarphiles to produce 
either the 3-Vinyl-4-Formyl-Isoxazolidine or the 3-Vinyl-5-Formyl-Isoxazolidine 
selectively. The scope of this reactions extends to aliphatic enals, conjugated nitriles and 
esters, and enones with a diverse substitution with no need for cumbersome purifications 
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while maintaining excellent yields. The high selectivity can be attributed to the 
orthogonal reactivity of bulky substituted conjugated carbonyls as enals and unsubstituted 
conjugated carbonyls as dipolarophiles. The regioselectivity of the diplolar cycloaddition 
is determined through the substitution pattern of the dipolarophile. The above-mentioned 
selectivity inhibits the formation of background products making the overall method 
simple and highly efficient. 
 
3.5 Experimental 
 Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar 
and used without further purification. Solvents were obtained from EMD Miliphore 
DrySol and degassed with nitrogen. Reactions were performed in 4- mL glass vials with 
magnetic stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates 
and visualized under UV light (254 nm) or by staining with potassium permanganate 
(KMnO4). Silica flash chromatography was performed on E. Merck 230-400 mesh silica 
gel 60. Automated chromatography was performed on a ISOLERA Prime instrument 
with 10 g. SNAP silica gel normal phase cartridges using a flow rate of 12.0 mL/min and 
a gradient of 0- 20% EtOAc in Heptanes over 12 column volumes with UV detection at 
254 nm. NMR spectra were recorded on Varian Mercury II 400 MHz Spectrometer at 24 
°C in CDCl3 unless otherwise indicated. Chemical shifts are expressed in ppm relative to 
solvent signals: CDCl3 (
1H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed in 
Hz). 
3.5.1. General method for the synthesis of Vinyl Isozazolidines. In a 4- mL 
glass vial, 1 mMol enal and 1.1 eq. hydroxylamine were dissolved in 1 mL acetonitrile. 
The mixture was stirred at room temperature for five minutes after which 3 molar 
equivalents dipolarphile was added. The reaction was stirred vigorously at 80°C for 16 
hours. The organic was extracted with 150 mL diethyl ether. The organic layer was 
washed with 3-25 mL aliquots of (10%) aqueous sodium bicarbonate. The organic layer 
was dried with 3-25 mL aliquots of saturated aqueous brine solution (NaCl). The organic 
layer is finally isolated and dried over anhydrous sodium sulfate, filtered, and 
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concentrated by rotary evaporation to afford the crude product. The crude product is 
filtered through silica gel over a gradient of 4:1 Heptanes/EtOAc over 12 column 
volumes to obtain the respective isoxazolidine in good to excellent yields. 
 
 3.5.2. Synthesis of Vinyl Isoxazolidines from Table 9 and 11. 
 
 
(3S,4S)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidine-4-carbaldehyde (T2A):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine 2a (115mg, 90%) as a yellow oil. TLC: Rf 0.20 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 9.74 (dd, J = 2.4, 0.7 Hz, 1H), 7.41 - 7.26 
(m, 7H), 6.89 - 6.82 (m, 2H), 6.60 (d, J = 15.8 Hz, 1H), 6.08 (dd, J = 15.8, 8.5 Hz, 1H), 
4.23 (dd, J = 8.9, 4.0 Hz, 1H), 4.15 - 4.07 (m, 2H), 3.80 (d, J = 0.7 Hz, 3H), 3.77 (d, J = 
14.0 Hz, 1H), 3.61 (t, J = 8.3 Hz, 1H), 3.31 (dddd, J = 8.3, 7.1, 3.9, 2.4 Hz, 1H). 13C NMR 
(101 MHz, CDCl3) δ 198.82, 159.67, 137.14, 134.53, 128.78, 128.26, 127.82, 127.30, 
123.05, 114.03, 65.45, 61.61, 55.27. 
 
 
(3S,4S,5R)-2-benzyl-3-((E)-4-methoxystyryl)-5-propylisoxazolidine-4-carbaldehyde 
(T2B): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 2b (100mg, 70%) as a yellow oil. TLC: Rf 
0.20 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 9.75 (dd, J = 2.7, 0.7 Hz, 1H), 
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7.52 - 7.24 (m, 7H), 6.96 - 6.84 (m, 2H), 6.54 (d, J = 15.8 Hz, 1H), 6.06 (dd, J = 15.7, 8.5 
Hz, 1H), 4.51 - 4.17 (m, 1H), 4.13 (d, J = 14.3 Hz, 1H), 3.81 (d, J = 0.7 Hz, 3H), 3.77 - 
3.61 (m, 1H), 3.01 (ddd, J = 7.8, 5.4, 2.7 Hz, 1H), 1.87 (dddd, J = 13.4, 9.7, 7.8, 5.6 Hz, 
1H), 1.60 (ddt, J = 13.5, 9.6, 5.9 Hz, 1H), 1.47 - 1.30 (m, 2H), 0.93 (td, J = 7.4, 3.1 Hz, 
3H). 13C NMR (101 MHz, CDCl3) δ 198.89, 159.62, 137.34, 133.85, 128.55, 128.16, 
127.81, 127.08, 123.69, 114.03, 76.92, 76.46, 67.75, 55.30, 37.26, 19.16, 13.87. 
 
 
(3S,4S,5R)-2-benzyl-3-((E)-4-methoxystyryl)-5-methylisoxazolidine-4-carbaldehyde 
(T2C): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 2c (85mg, 70%) as a plae oil. TLC: Rf 0.31 
(3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 9.76 (t, J = 2.0 Hz, 1H), 7.39 - 7.25 
(m, 9H), 6.88 - 6.85 (m, 2H), 6.53 (d, J = 15.9 Hz, 1H), 6.13 - 6.05 (m, 1H), 4.52 - 4.47 
(m, 1H), 4.13 (d, J = 14.2 Hz, 1H), 3.85 (d, J = 14.3 Hz, 1H), 3.81 (d, J = 1.5 Hz, 3H), 3.75 
(d, J = 6.7 Hz, 1H), 2.97 (s, 1H), 1.43 (dd, J = 6.2, 1.5 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 198.76 , 133.80 , 128.56 , 128.23 , 127.81 , 127.15 , 123.75 , 114.04 , 73.10 , 
68.94 , 59.37 , 55.30 , 20.72 . 
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(3R,5S)-2-benzyl-3-((E)-4-methoxystyryl)-5-methylisoxazolidine-5-carbaldehyde 
(T2D): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 2d (165mg, 90%) as a yellow oil. TLC: Rf 
0.35 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 9.59 (s, 1H), 7.39 (d, J = 7.1 
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Hz, 2H), 7.35 - 7.29 (m, 4H), 7.25 (tt, J = 6.0, 1.6 Hz, 1H), 6.93 - 6.78 (m, 2H), 6.53 (d, J 
= 15.8 Hz, 1H), 5.89 (ddd, J = 15.8, 8.8, 0.6 Hz, 1H), 4.19 (d, J = 14.8 Hz, 1H), 3.81 (d, J 
= 0.6 Hz, 3H), 3.76 (d, J = 14.8 Hz, 1H), 3.43 (q, J = 8.3 Hz, 1H), 2.52 (dd, J = 12.7, 7.8 
Hz, 1H), 2.25 (dd, J = 12.7, 8.4 Hz, 1H), 1.30 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 
205.12, 133.59, 128.35, 128.18, 127.72, 127.08, 124.71, 114.02, 69.67, 59.15, 55.30, 
44.00, 19.07.  
 
 
1-((3R,5S)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidin-5-yl)ethan-1-one (T2E): 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine 2e (180mg, 80%) as a yellow oil. TLC: Rf 0.45 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 7.1 Hz, 2H), 7.33 (ddd, J = 
4.3, 2.5, 1.3 Hz, 4H), 7.28 - 7.22 (m, 1H), 6.91 - 6.81 (m, 2H), 6.55 (d, J = 15.8 Hz, 1H), 
5.91 (dd, J = 15.8, 8.6 Hz, 1H), 4.28 (dd, J = 9.5, 4.7 Hz, 1H), 4.17 (d, J = 14.1 Hz, 1H), 
3.80 (d, J = 0.8 Hz, 3H), 3.69 (d, J = 14.1 Hz, 1H), 3.34 (q, J = 8.3 Hz, 1H), 2.71 (ddd, J = 
12.8, 9.4, 7.8 Hz, 1H), 2.38 (ddd, J = 13.0, 8.5, 4.7 Hz, 1H), 2.10 (d, J = 0.8 Hz, 3H). 13C 
NMR (101 MHz, Chloroform-d) δ 133.77, 128.88, 128.11, 127.68, 127.18, 124.50, 114.00, 
80.46, 69.38, 59.72, 55.27, 38.97, 25.35.  
 
 
1-((3R,5S)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidin-5-yl)propan-1-one(T2F): 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine 2f (105mg, 70%) as a pale oil. TLC: Rf 0.50 (3:1 
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heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.41 - 7.21 (m, 8H), 6.89 - 6.83 (m, 2H), 
6.54 (d, J = 15.8 Hz, 1H), 5.91 (dd, J = 15.9, 8.5 Hz, 1H), 4.33 (dd, J = 9.4, 4.9 Hz, 1H), 
4.16 (d, J = 14.1 Hz, 1H), 3.81 (d, J = 0.7 Hz, 3H), 3.69 (d, J = 14.1 Hz, 1H), 3.35 (q, J = 
8.3 Hz, 1H), 2.75 - 2.68 (m, 1H), 2.65 - 2.56 (m, 1H), 2.46 (ddd, J = 11.5, 7.2, 4.4 Hz, 1H), 
2.42 - 2.36 (m, 1H), 0.95 (td, J = 7.3, 0.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 159.51 
, 137.57 , 133.73 , 128.89 , 128.10 , 127.70 , 127.19 , 124.59 , 114.02 , 69.45 , 59.76 , 55.30 
, 39.09 , 30.54 , 7.13 . 
 
(3S,3aR,7aS)-2-benzyl-3-((E)-4-methoxystyryl)hexahydrobenzo[d]isoxazol-7(4H)-
one (T2G): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 2g (110mg, 65%) as a yellow oil. TLC: Rf 
0.15 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.40 - 7.34 (m, 2H), 7.34 - 7.26 
(m, 4H), 7.24 - 7.20 (m, 1H), 6.87 - 6.81 (m, 2H), 6.58 (d, J = 15.8 Hz, 1H), 6.09 - 6.00 
(m, 1H), 4.56 (dt, J = 7.7, 4.3 Hz, 1H), 4.09 (d, J = 14.1 Hz, 1H), 3.87 - 3.78 (m, 5H), 2.99 
(t, J = 6.7 Hz, 1H), 2.50 (dt, J = 17.0, 5.1 Hz, 1H), 2.33 (ddd, J = 16.6, 10.2, 6.1 Hz, 1H), 
2.06 - 1.96 (m, 1H), 1.95 - 1.87 (m, 2H), 1.86 - 1.78 (m, 1H). 13C NMR (101 MHz, CDCl3) 
δ 137.44 , 133.07 , 128.91 , 128.16 , 127.70 , 127.15 , 125.01 , 113.90 , 70.47 , 60.77 , 
55.24 , 39.88 , 26.43 , 19.01 . 
 
(3S,3aR,7aS)-2-benzyl-3-((E)-styryl)hexahydrobenzo[d]isoxazol-7(4H)-one (T4A): 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine 4a (165mg, 92%) as a white solid. TLC: Rf 0.25 (3:1 
heptanes/EtOAc).  1H NMR (400 MHz, CDCl3) δ 7.39 (dd, J = 8.2, 6.5 Hz, 4H), 7.32 (t, J 
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= 7.4 Hz, 4H), 7.28 - 7.23 (m, 2H), 6.67 (d, J = 15.9 Hz, 1H), 6.22 (dd, J = 15.9, 7.9 Hz, 
1H), 4.59 (dt, J = 7.8, 4.3 Hz, 1H), 4.10 (d, J = 14.0 Hz, 1H), 3.93 (dd, J = 7.9, 5.9 Hz, 1H), 
3.87 (d, J = 14.0 Hz, 1H), 3.01 (t, J = 6.6 Hz, 1H), 2.52 (dt, J = 16.8, 5.0 Hz, 1H), 2.36 
(ddd, J = 16.5, 10.2, 6.2 Hz, 1H), 2.09 - 1.99 (m, 1H), 1.93 (dq, J = 9.8, 4.4 Hz, 2H), 1.84 
(ddd, J = 14.0, 7.1, 3.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 209.20, 137.41, 136.48, 
133.49, 128.99, 128.55, 128.23, 127.82, 127.49, 127.25, 126.54, 76.77, 70.16, 60.75, 
60.50, 40.02, 26.42, 19.17. 
 
(3S,3aR,7aS)-2-benzyl-3-((E)-4-(dimethylamino)styryl)hexahydrobenzo[d]isoxazol-
7(4H)-one (T4B): Purification by automated silica gel flash chromatography (10 g 
cartridge, 14 ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in 
Heptanes over 12 column volumes) yielded the isoxazolidine 4b (178mg, 70%) as a red 
oil. TLC: Rf 0.19 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.40 - 7.28 (m, 
6H), 7.25 - 7.22 (m, 1H), 6.67 (dd, J = 8.9, 2.6 Hz, 2H), 6.56 (d, J = 15.8 Hz, 1H), 5.98 
(ddd, J = 15.7, 8.1, 1.0 Hz, 1H), 4.57 (dt, J = 7.6, 4.2 Hz, 1H), 4.12 (d, J = 14.1 Hz, 1H), 
3.80 (d, J = 10.6 Hz, 1H), 3.01 (t, J = 6.9 Hz, 1H), 2.96 (d, J = 1.0 Hz, 6H), 2.54 - 2.30 (m, 
3H), 2.09 - 1.92 (m, 2H), 1.91 - 1.82 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 209.42, 
150.26, 137.60, 133.80, 128.98, 128.17, 127.56, 127.13, 122.60, 122.53, 112.32, 76.72, 
70.95, 60.91, 60.13, 40.49, 39.81, 26.54, 18.96. 
 
(3S,3aR,7aS)-2-benzyl-3-(2-methylprop-1-en-1-yl)hexahydrobenzo[d]isoxazol-7(4H)-
one (T4D): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 4d (100mg, 88%) as a yellow oil. TLC: Rf 
0.40 (3:1 heptanes/EtOAc).  1H NMR (400 MHz, CDCl3) δ 7.36 - 7.28 (m, 4H), 7.25 - 7.21 
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(m, 1H), 5.19 (ddd, J = 9.4, 2.5, 1.3 Hz, 1H), 4.55 - 4.48 (m, 1H), 3.98 (d, J = 14.1 Hz, 1H), 
3.87 (s, 1H), 3.76 (d, J = 14.1 Hz, 1H), 2.88 (t, J = 7.3 Hz, 1H), 2.47 (dt, J = 17.0, 5.1 Hz, 
1H), 2.36 - 2.28 (m, 1H), 2.08 - 1.98 (m, 1H), 1.88 - 1.78 (m, 3H), 1.71 (dd, J = 16.9, 1.3 
Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 209.84, 137.68, 136.10, 128.81, 128.13, 127.08, 
76.57, 66.73, 61.00, 39.49, 26.65, 26.05, 18.67, 18.47. 
 
 
(3S,3aR,7aS)-2-benzyl-3-((E)-pent-1-en-1-yl)hexahydrobenzo[d]isoxazol-7(4H)-one 
(T4E): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 4e (110mg, 80%) as a yellow oil. TLC: Rf 
0.42 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.36 (dd, J = 5.9, 1.9 Hz, 3H), 
7.31 (d, J = 7.1 Hz, 2H), 5.70 (dt, J = 15.3, 6.8 Hz, 1H), 5.46 - 5.39 (m, 1H), 4.50 (dt, J = 
8.0, 4.2 Hz, 1H), 4.05 (d, J = 14.1 Hz, 1H), 3.75 (d, J = 14.1 Hz, 1H), 3.58 (t, J = 7.6 Hz, 
1H), 2.92 (t, J = 7.2 Hz, 1H), 2.50 - 2.45 (m, 1H), 2.31 (ddd, J = 16.7, 10.1, 6.2 Hz, 2H), 
2.01 (d, J = 7.3 Hz, 2H), 1.90 - 1.81 (m, 3H), 1.38 (d, J = 7.3 Hz, 2H), 0.87 (d, J = 7.3 Hz, 
3H). 13C NMR (101 MHz, CDCl3) δ 209.49, 137.56, 135.84, 128.92, 128.87, 128.16, 
127.12, 76.37, 70.71, 60.66, 59.94, 39.64, 34.39, 26.56, 22.13, 18.77, 13.59. 
 
(3S,3aR,7aS)-2-benzyl-3-((E)-prop-1-en-1-yl)hexahydrobenzo[d]isoxazol-7(4H)-one 
(T4F): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 4f (209mg, 70%) as a yellow oil. TLC: Rf 
0.38 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 7.0 Hz, 2H), 7.30 
(t, J = 7.4 Hz, 2H), 7.25 - 7.20 (m, 1H), 5.78 - 5.65 (m, 1H), 5.45 (ddd, J = 15.2, 8.4, 2.0 
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Hz, 1H), 4.48 (dt, J = 8.1, 4.2 Hz, 1H), 4.09 - 4.00 (m, 1H), 3.76 (dd, J = 19.8, 14.1 Hz, 
1H), 3.56 (t, J = 7.5 Hz, 1H), 2.90 (t, J = 7.3 Hz, 1H), 2.46 (dt, J = 16.5, 5.1 Hz, 1H), 2.34 
- 2.23 (m, 1H), 2.03 - 1.95 (m, 1H), 1.88 - 1.76 (m, 3H), 1.70 (dd, J = 6.5, 1.6 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ 209.51, 137.51, 130.50, 128.82, 128.06, 127.07, 76.26, 70.68, 
60.42, 39.54, 26.44, 18.63, 17.86. 
 
(3S,3aR,7aS)-2-benzyl-3-((1E,3E)-penta-1,3-dien-1-yl)hexahydrobenzo[d]isoxazol-
7(4H)-one (T4I): Purification by automated silica gel flash chromatography (10 g 
cartridge, 14 ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in 
Heptanes over 12 column volumes) yielded the isoxazolidine 4i (104mg, 80% yield) as a 
yellow oil. TLC: Rf 0.49 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.37 - 7.23 
(m, 5H), 6.25 (dd, J = 15.2, 10.4 Hz, 1H), 6.08 - 5.96 (m, 1H), 5.80 - 5.65 (m, 1H), 5.52 
(dd, J = 15.2, 8.1 Hz, 1H), 4.51 (ddt, J = 11.5, 7.7, 4.2 Hz, 1H), 4.04 (d, J = 14.1 Hz, 1H), 
3.74 (d, J = 14.1 Hz, 1H), 3.66 (t, J = 7.2 Hz, 1H), 2.92 (dd, J = 8.7, 5.2 Hz, 1H), 2.51 - 
2.43 (m, 1H), 2.35 - 2.27 (m, 1H), 2.03 - 1.95 (m, 1H), 1.91 - 1.84 (m, 2H), 1.80 (ddd, J = 
6.9, 5.4, 2.5 Hz, 1H), 1.77 - 1.73 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 209.31, 137.49, 
134.26, 130.62, 130.53, 128.85, 128.13, 127.11, 76.49, 70.31, 60.74, 39.73, 26.46, 18.84, 
18.07. 
 
3.5.3. Synthesis of Vinyl Isoxazolidines from Table 10. 
 
(3S,4R)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidine-4-carbonitrile (T3A): 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine 3a (80mg, 90%) as a pale oil. TLC: Rf 0.20 (3:1 
88 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.42 - 7.38 (m, 2H), 7.36 - 7.24 (m, 5H), 
6.95 - 6.83 (m, 2H), 6.68 (d, J = 15.8 Hz, 1H), 6.20 (dd, J = 15.8, 8.9 Hz, 1H), 4.30 (t, J = 
8.6 Hz, 1H), 4.18 (d, J = 14.3 Hz, 1H), 4.08 (dd, J = 8.4, 6.7 Hz, 1H), 3.82 (d, J = 0.5 Hz, 
3H), 3.71 (d, J = 14.3 Hz, 1H), 3.61 (td, J = 8.5, 6.7 Hz, 1H), 3.51 (t, J = 8.2 Hz, 1H). 13C 
NMR (101 MHz, CDCl3) δ 136.95 , 136.61 , 128.74 , 128.44 , 128.30 , 128.22 , 127.46 , 
119.86 , 114.09 , 69.99 , 68.68 , 55.33 , 38.48. 
 
 
tert-butyl-(3R,5S)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidine-5-carboxylate 
(T3B): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 3b (90mg, 90%) as a pale oil. TLC: Rf 0.56 
(3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.44 - 7.40 (m, 2H), 7.31 (dd, J = 
8.3, 6.0 Hz, 4H), 7.26 - 7.22 (m, 1H), 6.89 - 6.84 (m, 2H), 6.56 (d, J = 15.9 Hz, 1H), 5.99 
(dd, J = 15.8, 8.2 Hz, 1H), 4.50 (dd, J = 8.2, 5.2 Hz, 1H), 4.14 - 4.01 (m, 2H), 3.81 (d, J = 
0.8 Hz, 3H), 3.67 - 3.59 (m, 1H), 2.57 (t, J = 8.4 Hz, 2H), 1.51 (s, 9H). 13C NMR (101 
MHz, CDCl3) δ 171.23, 159.47, 137.79, 133.31, 128.98, 128.24, 127.67, 127.12, 124.40, 
114.02, 81.69, 75.64, 68.04, 60.68, 55.29, 40.66, 28.04. 
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Methyl-(3R,5S)-2-benzyl-3-((E)-4-methoxystyryl)-5-methylisoxazolidine-5-
carboxylate (T3C): Purification by automated silica gel flash chromatography (10 g 
cartridge, 14 ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in 
Heptanes over 12 column volumes) yielded the isoxazolidine 3c (105mg, 90%) as a yellow 
oil. TLC: Rf 0.50 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.47 - 7.37 (m, 
89 
2H), 7.30 (ddd, J = 8.2, 4.4, 1.5 Hz, 4H), 7.25 - 7.19 (m, 1H), 6.93 - 6.79 (m, 2H), 6.50 (d, 
J = 15.9 Hz, 1H), 5.95 (ddd, J = 15.8, 8.7, 1.3 Hz, 1H), 4.20 (d, J = 15.4 Hz, 1H), 3.86 - 
3.74 (m, 7H), 3.44 (q, J = 8.4 Hz, 1H), 2.82 (ddd, J = 12.8, 8.6, 1.3 Hz, 1H), 2.31 (ddd, J = 
12.9, 8.0, 1.4 Hz, 1H), 1.57 (s, 1H), 1.50 (d, J = 1.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ 159.45, 137.53, 133.50, 129.08, 128.18, 128.01, 127.68, 126.77, 124.72, 113.98, 81.10, 
69.44, 58.71, 55.28, 52.32, 46.07, 23.71. 
 
dibutyl (3S,4R,5S)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidine-4,5-dicarboxylate 
(T3D): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 3d (120mg, 90%) as a white solid. TLC: Rf 
0.62 (3:1 heptanes/EtOAc).  1H NMR (400 MHz, CDCl3) δ 7.43 - 7.37 (m, 2H), 7.34 - 7.28 
(m, 4H), 7.26 - 7.21 (m, 1H), 6.91 - 6.83 (m, 2H), 6.63 (d, J = 15.8 Hz, 1H), 5.97 (dd, J = 
15.8, 8.5 Hz, 1H), 4.21 - 4.14 (m, 2H), 4.12 - 4.02 (m, 4H), 3.91 (t, J = 9.0 Hz, 1H), 3.81 
(d, J = 0.6 Hz, 3H), 3.67 - 3.60 (m, 1H), 1.67 - 1.54 (m, 4H), 1.44 - 1.30 (m, 4H), 0.91 
(ddd, J = 29.9, 7.6, 7.1 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 169.22, 159.68, 137.34, 
135.24, 128.99, 128.83, 128.25, 127.87, 127.27, 122.01, 114.01, 76.67, 72.19, 65.23, 
60.25, 56.97, 55.31, 30.45, 19.07, 13.68. 
 
diethyl (3S,4S,5S)-2-benzyl-3-((E)-4-methoxystyryl)isoxazolidine-4,5-dicarboxylate 
(T3E): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 3e (118mg, 90%) as a white solid. TLC: Rf 
0.35 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.46 - 7.43 (m, 2H), 7.33 (dq, 
90 
J = 8.7, 2.3, 1.5 Hz, 4H), 7.29 (d, J = 1.5 Hz, 1H), 6.88 - 6.85 (m, 2H), 6.62 (d, J = 15.8 
Hz, 1H), 6.02 (dd, J = 15.9, 8.6 Hz, 1H), 4.87 (d, J = 4.3 Hz, 1H), 4.24 (tdd, J = 15.0, 7.5, 
3.7 Hz, 5H), 3.86 (d, J = 15.2 Hz, 1H), 3.81 (s, 3H), 3.74 (dd, J = 8.2, 4.3 Hz, 1H), 3.65 - 
3.58 (m, 1H), 1.31 (d, J = 7.1 Hz, 3H), 1.25 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 171.35, 171.04, 159.67, 137.22, 135.12, 128.85, 128.10, 128.08, 127.87, 126.96, 
122.64, 114.02, 77.16, 73.48, 61.59, 61.50, 58.74, 57.28, 55.30, 14.19, 14.12. 
 
3.5.4. 1H NMR and 13C NMR of Vinyl Isoxazolidines. 
 
91 
 
 
92 
 
 
93 
 
 
94 
 
 
95 
 
 
96 
 
 
97 
 
 
98 
 
 
99 
 
 
100 
 
 
 
 
 
 
 
 
101 
Chapter 4: 
 
Nitrone Intramolecular Cycloaddition 
 
4.1 Pharmaceutical Relevance 
 Proposed by Smith129, the 1,3-dipolar cycloaddition reaction is an outstanding 
methodology for the synthesis of five-membered-ring-containing heterocycles.116, 117, 130-
133 This reaction involves the combination of a 1,3-dipole with a dipolarophile. The 
methodology of this reaction found widespread application in a variety of fields like 
materials science, natural product synthesis, and biological chemistry. This methodology 
gained recognition in the 1960s through seminal work by Huisgen.134-136 Among the 1,3-
dipoles the nitrone stands out as the most widely employed in dipolar cycloadditions.137-143 
Their high stability along with their ease of access and biological significance may be why 
nitrones are so widely used. Depending on the dipolarophile and isoxazole or isoxazolidine 
skeletons are formed in their reactions with alkenes or alkynes, respectively. These 
heterocycles are found in a variety of natural products and can be converted into 1,3-amino 
alcohols, which are precursors of β-amino acids and β-lactams, through reductive ring 
opening.144 
 
4.2 Chromeoisoxazole Methodology  
 Formation of the chromeoisoxazole (Figure 13) has been limited to methods using 
heat145 and grinding.146 These methods while affective are often times tedious and wasteful. 
The use of photocatalysts has become widely used in organic chemistry to facility reactions 
that would either never happen or would be extremely slow147, 148 
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Figure 13. Formation of Chromeoisoxazole Using a Zinc Catalyst Under Mild Conditions 
 
 
 
Zhao was able to form the chromeoisoxazoles in good yields as a mixture of 
diastereomers. These chromeoisoxazoles were formed using a nitrone, this was formed 
through the condensation of a hydroxylamine and an aldehyde using 5% mol glacial acetic 
acid. This was able to lead to the nitrone (Figure 14). With the nitrone Zhao was then able 
to form the chromeoisokxazole by refluxing the nitrone in chloroform for 48 hours at 40˚C 
(Figure 15). This reaction lead to a mixture of diastereomers in good yields.145 
 
 
 
 
 
Figure 14. Nitrone formation from Zhao 
 
 
 
 
Figure 15. Chromeoisoxazole formation from Zhao 
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 Compared to using heat for this reaction another method that is employed is 
grinding149, 150. Bhutia used two types of grinding tests to determine the best method for 
the formation of chromeoisoxazoles. The first method was a gentle grinding where they 
found that after 15 minutes the nitrone was formed while gentle heating was required for 
the formation of the chromeoisoxazole instead of intermediate grinding for 12 hours at 
room temperature. The other method employed was liquid assisted grinding (LAG).151 
This method compared three solvents: chloroform, ethanol, and acetonitrile. These three 
solvents showed similar speeds for the formation of the nitrone compared to the gentle 
grinding method. The chromeoisoxazole formation was low yielding and so Bhutia stuck 
with the gentle grinding method.  
 Photocatalyzed reactions have become a major field in organic chemistry over the 
past few years, mainly due to visible light being in natural abundance, environmentally 
benign, renewable, and easy to handle.147, 152-157 The rapid development of this field has 
led to the development of new and simpler organic reactions. These reactions range from 
coupling reactions158, alkyl-vinyl product formation159, sulfur ylides formation160, and 
ring closing reactions161, 162 to name a few. Tris(2,2′-bipyridyl)dichlororuthenium(II) 
hexahydrate (Ru(bpy)3Cl2•6H2O) has been used in an oxidative cross-dehydrogenative 
coupling (CDC).163  
 The CDC method used glycine and styrene as substrates to explore the reaction 
conditions.163 The screening began with the use of Ru(bpy)3(PF6)2 in 1 mol percent in 
combination with 10 mol percent of a Lewis acid cocatalyst Cu(OTf)2 in acetonitrile 
under irradiation of a 3W blue LED bulb for 4 hours. Upon further screening 
Ru(bpy)3Cl2•6H2O was found to be the best photocatalyst under these conditions and 
gave a yield of 75% after 4 hours. With further testing it was found that the best Lewis 
acid cocatalyst was Cu(OTf)2 while acetonitrile proved to be the best medium and the 
photocatalyst could be reduced to 1 mol percent. Further testing of the light source 
showed that under a 26W fluorescent lamp the reaction was able to proceed to 
completion but was slower to complete at 15 hours. Under the irradiation of direct 
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sunlight, the reaction was able to proceed in 6 hours affording a 74% yield which helped 
to show the utility of the protocol. Zhang also found that molecular oxygen played a role 
in the system upon finding that the reaction did not yield the desired product under argon. 
The conditions were able to show that substituted styrenes, naphtyl ethylenes, 1,2-
disubstituted alkenes, aliphatic alkenes, and conjugated dienes. It was noted by Zhang 
that the aliphatic alkenes had reduced yields compared to their styrene counter parts. 
Alkenes with strong electron-withdrawing groups were also noted to not be suited for this 
reaction.  
 The scope of the glycine esters were also explored by Zhang and were found to 
give relatively good yields. Para-substituted glycine’s were found to give the best yields 
for these conditions, it was also noted that 3,5-dimethyl substituted glycine was also able 
to obtain a relatively lower yield of the product. The ester fragment was also explored by 
Zhang and found that small, large, and bulky ester were suitable for this reaction along 
with glycine amide and glycine derived dipeptide. Other substrates tried were α-amino 
carbonyls species such as ketones and amino nitriles, but these were found to give trace 
products or no reaction respectively. 
 
4.3 Results and Discussion 
 Since a photocatalyst was being used for this transformation multiple catalysts were 
tested to see which was the best. These tests were run in the solvent acetonitrile due to 
some of the catalysts not dissolving in other medium. These catalysts tended to allow the 
product to undergo hydrolysis back to the starting aldehyde or they caused no reaction at 
all. Ru(Bpy)3 is a common photocatalyst used in many different organic synthesis methods 
and provided an 82% yield of the product (Table 12, Entry 1). Other metal catalysts were 
used that are found in light mediated organic synthesis and they were found to give good 
to moderate yields (Table 12, Entry 2-4). Two organic photocatalysts were also used and 
were found to give poor yields or no reaction (Table 12, Entry 5-6).  
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Table 12 
Catalyst Optimization Table 
 
 
 
 
The formation of chromeoisoxazoles has been traditionally done using high heats. 
During the optimization process of these compounds the existing methods were tested to 
observe the viability of this reaction (Table 13, Entry 3). Optomization then focused on 
visible light after a nitrone was placed on the windowsill to react overnight (Table 13, Entry 
5). It was observed that by decreasing the concentration of the reaction the yields would 
increase significantly (Table 13, Entry 8-11). Upon the addition of a photocatalyst the 
yields are observed to increase even further when added in five molar percent (Table 13, 
Entry 12). Through the addition of triethylamine, it was observed that the reaction yields 
became excellent. This is due to a possible radical mechanism involving the triethylamine 
(Figure 16). 
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Figure 16. Proposed Mechanism for the Formation of Chromenoisoxazoles 
 
 
 
Table 13 
Chromeoisoxazole Synthesis Optomization 
Entry Solvent Concentration YieldaAdditive
None
visible light
Benzene
Benzene
Benzene
ACNvisible light
Benzene
0.01M
0.01M
0.01M
0.01M
0.01M
0%
32%
91%
18%
20%
1
2
3
4
5
a.Isolated yields.
none
none
rt
60o C
80o C
rt
rt
CH2Cl2
MeOH
0.01M
0.01M
0.02M
0.03M
0.05M
32%
28%
18%
15%
32%
6
7
8
9
10
visible light
visible light
rt
rt
rt
rt
rt
0.005M
0.005M
0.005M
42%
64%
44%
11
12
13
rt
rt
rt
ACNRu(bpy)3Cl2 5mol%
visible light ACN
ACNvisible light
ACN
ACN
visible light
visible light
ACNRu(bpy)3Cl2 1mol%
0.005M 55%14 rtACNRu(bpy)3Cl2 10mol%
O
ON
Bn
H
H
O
N
OBn
solvent
additive
0.005M
0.005M
98%
95%
15
16
rt
rt
ACNRu(bpy)3Cl2 5%/Et3N 1 equiv
ACNRu(bpy)3Cl2 5%/Et3N 1.5equiv
T
 
 
 
107 
 
 With the optimal condition in hand for this reaction we sought to determine the 
scope. Different substitution around the aromatic ring was tested for these reactions such 
as the meta position which showed excellent yields (Table 14, Entry 2). A fused ring was 
also test and was found to have excellent yields as well (Table 14, Entry 3). Multiple 
substitutions around the aromatic ring were tested all found to produce excellent yields 
(Table 14, Entry 4-6 and 10-12). Electron donating groups were also found to give 
excellent yields (Table 14, Entry 2 and 7). Electron withdrawing groups were tested as well 
and no difference between the donating and withdrawing groups were noticed (Table 14, 
Entry 4-6, 8, 10-12). As expected ketones were found to produce excellent yields as well 
(Table 14, Entry 10-12). 
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Table 14 
Chromeoisoxazole Synthesis Aromatic Scope 
Entry Yielda,b
a. Reaction conditions: Nitrone (1 mmol), Ru(bpy)3 (0.05 mmol), Et3N (1 mmol) in ACN for 12h. b. Isolated yields.
c. Reaction crude was purified by standard silica gel chromatography.
Nitrone Productc
1
2
3
7
8
9
10
11
98%
97%
92%
95%
94%
93%
95%
96%
92%
96%
Entry Yielda,bNitrone Productc
Ru(bpy)3 (5 mol%)
O
ON
Bn
H
H
O
N
OBn
ACN, Et3N
R1 R
1
O
ON
Bn
H
H
O
N
OBn
O
ON
Bn
H
H
O
N
OBn
O
ON
Bn
H
H
O
N
OBn
O
ON
Bn
H
H
O
N
OBn
I
I
I
I
O
ON
Bn
H
H
O
N
OBn
Cl
Cl
Cl
Cl
O
ON
Bn
H
H
O
N
OBn
O
ON
Bn
H
H
F
O
N
OBn
F
O
ON
Bn
H
O
N
OBn
O
ON
Bn
H
Cl
O
N
OBn
Cl
Br Br
O
ON
Bn
H
Cl
O
N
OBn
Cl
O
ON
Bn
H
H
O
N
OBn
Br
Br
Br
Br
O
ON
Bn
H
O
N
OBn
NO2 NO2
91% 90%
4
5
6 12
 
 
 
 
 We also wanted to test if changed the allyl ether group in the ortho position would 
have any effect on the reaction. When placing methyl groups on the 1, 2, and 3 positions 
the yields all trended towards excellent and did not deviate from each other to any 
significant degree (Table 15, Entry 1-3). Bulky groups were tested to determine if there 
would be any significant effects on the yields and upon testing were found to also be 
excellent yielding (Table 15, Entry 4-5). 
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Table 15 
Chromeoisoxazole Synthesis Allyl Ester Scope 
 
 
 
 
 The robustness of this reaction was also attested by changing the hydroxylamine 
used during the nitrone formation. Small groups were tested and found to form the 
cycloadduct in excellent yields (Table 16, Entry 3). Likewise, bulky groups were tested 
and found to oxidize back to the aldehyde and did not form the desired product. Finally, 
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two different types of rings were tested an aromatic and a nonaromatic both of which 
formed the chromeoisoxazole in excellent yields (Table 16, Entry 4 and 1). 
 
 
 
Table 16 
Chromeoisoxazole Synthesis Hydroxylamine Scope 
 
 
 
 
4.4 Conclusion 
 Using visible light and a photocatalyst the formation of chromeoisoxazole has 
been shown without requiring harsh conditions. Multiple substitutions on the aromatic 
ring have shown no difference in yield while providing diverse substitutions of the 
aromatic ring. Changing the allyl ether has also shown to form the chromeoisoxazole in 
excellent yields. The mechanism for the formation of the chromeoisoxazoles has been 
proposed via a catalytic mechanism involving a radical. 
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4.5 Experimental 
 Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar 
and used without further purification. Solvents were obtained from EMD Miliphore 
DrySol and degassed with nitrogen. Reactions were performed in 4- mL glass vials with 
magnetic stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates 
and visualized under UV light (254 nm) or by staining with potassium permanganate 
(KMnO4). Silica flash chromatography was performed on E. Merck 230-400 mesh silica 
gel 60. Automated chromatography was performed on a ISOLERA Prime instrument 
with 10 g. SNAP silica gel normal phase cartridges using a flow rate of 12.0 mL/min and 
a gradient of 0- 20% EtOAc in Heptanes over 12 column volumes with UV detection at 
254 nm. NMR spectra were recorded on Varian Mercury II 400 MHz Spectrometer at 24 
°C in CDCl3 unless otherwise indicated. Chemical shifts are expressed in ppm relative to 
solvent signals: CDCl3 (
1H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed in 
Hz). 
 
 4.5.1. General method for the synthesis of Chromeoisoxazoles. 
In a 20- mL glass vial, 1 eq. nitrone and 0.05 eq. Ru(Bpy)3 were dissolved in 7mL 
acetonitrile. The reaction was stirred vigorously under white light for 22 hours at room 
temperature. The substrate is concentrated by rotary evaporation to afford the crude 
product. The crude product is filtered through silica gel over a gradient of 9:1 
Heptanes/EtOAc over 12 column volumes to obtain the respective chromeoisoxazole in 
good to excellent yields. 
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4.5.2. Chromeoisoxazoles from Table 14. 
 
 
 
 
1-benzyl-9b-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (18.6mg, 93%) as a white solid. TLC: Rf 0.20 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.49 - 7.44 (m, 1H), 7.37 (d, J = 7.6 
Hz, 2H), 7.33 - 7.27 (m, 2H), 7.27 - 7.15 (m, 2H), 6.98 (t, J = 7.5 Hz, 1H), 6.89 (d, J = 
8.5 Hz, 1H), 4.28 - 4.14 (m, 3H), 4.01 - 3.82 (m, 3H), 2.84 - 2.76 (m, 1H), 1.56 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 128.59 , 128.49 , 128.37 , 128.21 , 126.94 , 121.21 , 
117.07 , 67.05 , 65.28 , 54.95 . 
 
 
 
 
1-benzyl-6-bromo-8-chloro-9b-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-
c]isoxazole: Purification by automated silica gel flash chromatography (10 g cartridge, 
14 ml/min. 2 column volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes 
over 12 column volumes) yielded the isoxazolidine (19mg, 95%) as a yellow solid. TLC: 
Rf 0.40 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, Chloroform-d) δ 7.44 - 7.37 (m, 4H), 
7.32 (td, J = 7.5, 1.8 Hz, 2H), 7.28 - 7.24 (m, 1H), 4.43 - 4.37 (m, 1H), 4.30 - 4.20 (m, 
2H), 4.02 - 3.85 (m, 3H), 2.85 (dddd, J = 9.0, 6.0, 4.4, 2.8 Hz, 1H). 13C NMR (101 MHz, 
Chloroform-d) δ 137.63 , 131.68 , 128.40 , 128.38 , 128.33 , 128.31 , 127.70 , 127.68 , 
127.21 , 127.19 , 66.87 , 65.34 , 64.22 , 55.02 , 29.69 , 23.65 . 
O
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1-benzyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column volumes 
of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column volumes) 
yielded the isoxazolidine (19.6mg, 98%) as a yellow solid. TLC: Rf 0.52 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.44 - 7.40 (m, 2H), 7.34 (td, J = 7.5, 
6.9, 1.1 Hz, 2H), 7.30 - 7.25 (m, 1H), 7.19 (dd, J = 8.4, 6.5 Hz, 2H), 6.95 - 6.87 (m, 2H), 
4.32 (td, J = 8.2, 0.9 Hz, 1H), 4.25 (d, J = 13.2 Hz, 1H), 4.19 - 4.16 (m, 2H), 4.04 (d, J = 
13.1 Hz, 1H), 3.95 (d, J = 6.9 Hz, 1H), 3.83 (dd, J = 8.1, 4.7 Hz, 1H), 3.14 - 3.05 (m, 
1H). 13C NMR (101 MHz, CDCl3) δ 130.84 , 129.05 , 128.95 , 128.39 , 127.42 , 121.21 , 
117.01 , 67.57 , 65.70 , 61.70 , 60.44 , 39.84 . 
 
 
 
 
1-benzyl-6,8-dichloro-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 
column volumes) yielded the isoxazolidine (18.8mg, 94%) as a yellow solid. TLC: Rf 
0.38 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.44 - 7.36 (m, 4H), 7.33 (d, J 
= 7.0 Hz, 1H), 7.25 (d, J = 2.4 Hz, 1H), 6.99 (d, J = 2.4 Hz, 1H), 4.35 (t, J = 8.3 Hz, 1H), 
4.27 - 4.19 (m, 2H), 4.10 (d, J = 2.1 Hz, 2H), 4.01 (d, J = 7.3 Hz, 1H), 3.90 (dd, J = 8.3, 
5.1 Hz, 1H), 3.21 - 3.11 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 136.63 , 129.16 , 
129.11 , 129.07 , 128.93 , 128.63 , 127.83 , 67.44 , 66.26 , 61.03 , 60.69 , 39.66 . 
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1-benzyl-8-fluoro-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column volumes 
of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column volumes) 
yielded the isoxazolidine (19.2mg, 96%) as a brown solid. TLC: Rf 0.3 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.46 - 7.42 (m, 2H), 7.37 (td, J = 7.7, 
7.3, 1.6 Hz, 2H), 7.32 (dd, J = 7.0, 1.6 Hz, 1H), 6.91 - 6.80 (m, 3H), 4.35 (td, J = 8.3, 1.3 
Hz, 1H), 4.16 - 4.11 (m, 4H), 4.01 (d, J = 7.3 Hz, 1H), 3.89 (ddd, J = 8.1, 5.1, 1.3 Hz, 
1H), 3.19 - 3.10 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 136.95 , 129.11 , 128.56 , 
127.68 , 118.07 , 117.99 , 116.50 , 116.27 , 115.99 , 115.76 , 67.63 , 65.75 , 61.26 , 60.71 
, 39.88 . 
 
 
 
 
 
6-allyl-1-benzyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column volumes 
of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column volumes) 
yielded the isoxazolidine (19.4mg, 97%) as a yellow solid. TLC: Rf 0.56 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.45 - 7.41 (m, 2H), 7.37 - 7.33 (m, 
2H), 7.31 - 7.26 (m, 1H), 7.08 (d, J = 7.6 Hz, 2H), 6.89 (t, J = 7.5 Hz, 1H), 6.00 (ddt, J = 
17.8, 9.5, 6.5 Hz, 1H), 5.08 - 5.03 (m, 2H), 4.34 - 4.25 (m, 2H), 4.18 (d, J = 5.9 Hz, 2H), 
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4.03 (d, J = 13.2 Hz, 1H), 3.95 (d, J = 7.0 Hz, 1H), 3.83 (dd, J = 8.1, 4.6 Hz, 1H), 3.39 
(dd, J = 6.7, 2.1 Hz, 2H), 3.13 - 3.04 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 136.78 , 
129.34 , 128.96 , 128.89 , 128.37 , 127.38 , 120.79 , 115.45 , 67.63 , 65.90 , 62.09 , 60.46 
, 40.04 , 34.07 . 
 
 
 
 
 
1-benzyl-6,8-diiodo-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (19.0mg, 95%) as a yellow solid. TLC: Rf 0.37 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 2.1 Hz, 1H), 7.44 - 7.29 
(m, 6H), 4.34 (td, J = 8.2, 0.8 Hz, 1H), 4.25 - 4.22 (m, 2H), 4.10 (s, 2H), 3.97 (d, J = 7.1 
Hz, 1H), 3.88 (dd, J = 8.3, 4.8 Hz, 1H), 3.18 - 3.09 (m, 1H). 13C NMR (101 MHz, 
CDCl3) δ 145.82 , 139.60 , 136.61 , 129.09 , 128.61 , 127.84 , 124.35 , 83.96 , 67.44 , 
66.55 , 61.20 , 60.75 , 39.92 . 
 
 
 
 
1-benzyl-6,8-diiodo-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (19.2mg, 96%) as a brown solid. TLC: Rf 0.4 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.60 - 7.52 (m, 1H), 7.38 (d, J = 5.6 
Hz, 3H), 7.34 - 7.29 (m, 2H), 7.26 - 7.21 (m, 1H), 6.76 (s, 1H), 4.26 - 4.19 (m, 2H), 4.11 
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(dd, J = 11.5, 3.1 Hz, 1H), 3.91 - 3.83 (m, 2H), 2.77 (dtd, J = 8.9, 5.4, 3.2 Hz, 1H), 2.30 
(s, 3H), 1.57 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 138.08 , 129.94 , 128.72 , 128.57 , 
128.45 , 128.41 , 128.24 , 127.05 , 126.99 , 119.09 , 66.97 , 63.32 , 54.90 , 29.69 , 19.80 . 
 
 
 
 
 
1-benzyl-6-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (18.4mg, 92%) as a brown-yellow solid. TLC: Rf 
0.48 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.48 - 7.45 (m, 1H), 7.42 - 
7.36 (m, 2H), 7.34 - 7.29 (m, 1H), 7.10 (t, J = 8.4 Hz, 2H), 6.89 (td, J = 7.5, 1.3 Hz, 1H), 
4.35 - 4.29 (m, 2H), 4.25 - 4.20 (m, 2H), 4.05 (d, J = 13.3 Hz, 1H), 3.95 (d, J = 6.9 Hz, 
1H), 3.85 (dd, J = 8.1, 4.6 Hz, 1H), 3.08 (qt, J = 6.5, 4.8 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 137.65 , 130.23 , 128.98 , 128.46 , 128.40 , 127.39 , 120.56 , 120.01 , 67.62 , 
65.88 , 62.16 , 60.44 , 39.98 , 16.13 . 
 
 
 
 
 
1-benzyl-6-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (18.0mg, 90%) as a yellow solid. TLC: Rf 0.24 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.56 - 7.50 (m, 2H), 7.39 (d, J = 7.3 
Hz, 2H), 7.35 - 7.30 (m, 2H), 7.28 - 7.23 (m, 1H), 4.42 (dd, J = 11.7, 4.5 Hz, 1H), 4.34 - 
4.24 (m, 2H), 4.04 - 3.87 (m, 3H), 2.93 - 2.86 (m, 1H), 2.34 (s, 3H), 1.61 (s, 3H). 13C 
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NMR (101 MHz, CDCl3) δ 133.93 , 130.12 , 128.45 , 128.34 , 127.23 , 124.95 , 66.92 , 
65.27 , 63.93 , 54.99 , 45.90 , 23.79 , 20.59 . 
 
 
 
 
 
 
1-benzyl-6,8-dibromo-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 
column volumes) yielded the isoxazolidine (18.2mg, 91%) as a yellow solid. TLC: Rf 
0.33 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 2.3 Hz, 1H), 7.44 
- 7.35 (m, 4H), 7.34 - 7.29 (m, 1H), 7.15 (d, J = 2.3 Hz, 1H), 4.35 (t, J = 8.3 Hz, 1H), 
4.26 (d, J = 5.1 Hz, 2H), 4.10 (s, 2H), 4.01 (d, J = 7.2 Hz, 1H), 3.90 (dd, J = 8.3, 4.9 Hz, 
1H), 3.16 (td, J = 7.7, 5.0 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 136.59 , 134.67 , 
132.59 , 129.10 , 128.76 , 128.62 , 127.84 , 67.45 , 66.38 , 61.13 , 60.71 , 39.74 . 
 
 
 
 
 
 
3-benzyl-3,3a,11,11a-tetrahydro-1H-benzo[7,8]chromeno[4,3-c]isoxazole: 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 
column volumes) yielded the isoxazolidine (18.4mg, 92%) as a yellow solid. TLC: Rf 
0.28 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.84 - 7.66 (m, 3H), 7.40 
(dhept, J = 20.6, 7.3 Hz, 7H), 7.10 (d, J = 8.9 Hz, 1H), 4.88 (d, J = 7.7 Hz, 1H), 4.47 (t, J 
= 8.6 Hz, 1H), 4.30 - 3.94 (m, 5H), 3.37 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 137.48 , 
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129.86 , 129.41 , 128.43 , 128.35 , 127.60 , 126.46 , 123.69 , 118.61 , 68.01 , 66.26 , 
59.02 , 58.93 , 40.62 . 
 
4.5.3. Chromeoisoxazoles from Table 15. 
 
 
 
 
1-benzyl-3a-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (18.8mg, 94%) as a brown-orange solid. TLC: Rf 
0.63 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.43 - 7.38 (m, 2H), 7.31 
(ddd, J = 7.6, 6.3, 1.4 Hz, 2H), 7.27 - 7.20 (m, 3H), 6.97 - 6.89 (m, 2H), 4.37 (d, J = 13.6 
Hz, 1H), 4.25 - 4.14 (m, 2H), 4.05 - 3.95 (m, 2H), 3.87 (d, J = 6.8 Hz, 1H), 2.49 (tt, J = 
7.4, 5.0 Hz, 1H), 1.38 (d, J = 6.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 130.97 , 
129.26 , 128.77 , 128.39 , 128.21 , 127.17 , 121.01 , 117.16 , 74.84 , 65.44 , 62.32 , 60.53 
, 46.68 , 29.69 . 
 
 
 
 
1-benzyl-4-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (19.2mg, 96%) as a white solid. TLC: Rf 0.45 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.47 - 7.41 (m, 2H), 7.36 (ddt, J = 7.4, 
5.7, 1.2 Hz, 2H), 7.31 - 7.23 (m, 3H), 6.99 - 6.93 (m, 2H), 4.43 (d, J = 13.6 Hz, 1H), 4.29 
(ddd, J = 8.5, 7.6, 1.2 Hz, 1H), 4.20 (dq, J = 12.0, 6.6 Hz, 1H), 3.97 (d, J = 13.4 Hz, 1H), 
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3.85 - 3.73 (m, 2H), 2.63 (dtdd, J = 9.8, 6.3, 3.5, 1.1 Hz, 1H), 1.43 (dd, J = 6.3, 1.3 Hz, 
3H). 13C NMR (101 MHz, CDCl3) δ 137.71 , 130.79 , 129.29 , 128.83 , 128.35 , 127.31 , 
120.77 , 117.09 , 71.76 , 67.83 , 62.62 , 60.41 , 46.08 , 19.44 . 
 
 
 
 
 
\1-benzyl-3-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (19.4mg, 97%) as a white solid. TLC: Rf 0.43 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 12.1 Hz, 2H), 7.37 - 7.30 
(m, 2H), 7.29 - 7.21 (m, 3H), 6.95 (td, J= 8.3, 3.9 Hz, 2H), 4.39 (dd, J = 13.6, 4.1 Hz, 
1H), 4.27 - 4.14 (m, 2H), 4.06 - 3.96 (m, 2H), 3.88 (t, J = 5.2 Hz, 1H), 2.50 (dt, J = 9.8, 
4.8 Hz, 1H), 1.42 - 1.37 (m, 3H).  13C NMR (101 MHz, CDCl3) δ 131.01 , 129.28 , 
128.80 , 128.79 , 128.23 , 127.18 , 121.03 , 117.18 , 74.85 , 65.47 , 62.35 , 60.57 , 46.70 , 
20.10 . 
 
 
 
 
 
 
 
1-benzyl-3a-methyl-3-(4-methylpent-3-en-1-yl)-1,3a,4,9b-tetrahydro-3H-
chromeno[4,3-c]isoxazole: Purification by automated silica gel flash chromatography 
(10 g cartridge, 14 ml/min. 2 column volumes of 100% Heptanes followed by 0-15% 
EtOAc in Heptanes over 12 column volumes) yielded the isoxazolidine (18.6mg, 93%) as 
a white solid. TLC: Rf 0.63 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.39 
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(d, J = 7.3 Hz, 2H), 7.26 (ddd, J = 13.0, 9.3, 2.8 Hz, 5H), 6.95 - 6.90 (m, 2H), 5.10 (td, J 
= 7.2, 3.5 Hz, 1H), 4.48 (d, J = 14.1 Hz, 1H), 4.31 (td, J = 10.2, 9.7, 3.1 Hz, 1H), 4.21 
(dd, J = 10.8, 4.9 Hz, 1H), 3.95 (dd, J = 14.5, 3.0 Hz, 1H), 3.85 (d, J = 5.8 Hz, 1H), 2.57 
(dt, J = 10.3, 5.3 Hz, 1H), 2.07 (dt, J = 11.9, 6.8 Hz, 2H), 1.69 (d, J = 3.3 Hz, 3H), 1.61 
(d, J = 3.6 Hz, 3H), 1.26 (d, J = 4.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 131.14 , 
129.31 , 128.33 , 128.05 , 126.80 , 123.87 , 120.62 , 116.97 , 64.75 , 62.89 , 59.86 , 45.83 
, 42.81 , 25.67 , 23.12 , 20.42 . 
 
 
 
 
 
1-benzyl-3,3-dimethyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 
column volumes) yielded the isoxazolidine (18.4mg, 92%) as a white solid. TLC: Rf 0.55 
(3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 7.3 Hz, 2H), 7.31 - 
7.20 (m, 5H), 6.95 - 6.89 (m, 2H), 4.49 (dd, J = 14.3, 2.7 Hz, 1H), 4.37 - 4.20 (m, 2H), 
4.02 - 3.91 (m, 2H), 2.49 (tt, J = 7.7, 2.9 Hz, 1H), 1.38 (d, J = 2.7 Hz, 3H), 1.30 (d, J = 
2.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 131.03 , 129.31 , 128.30 , 128.08 , 126.84 , 
120.63 , 116.98 , 64.55 , 62.68 , 60.01 , 47.50 , 30.12 , 22.71 . 
 
 
 
 
 
 
1-benzyl-3-phenyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
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volumes) yielded the isoxazolidine (19.2mg, 96%) as a white solid. TLC: Rf 0.5 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.45 (dt, J = 6.5, 1.6 Hz, 5H), 7.41 - 
7.29 (m, 6H), 7.29 - 7.21 (m, 3H), 6.98 - 6.92 (m, 2H), 4.42 (d, J = 13.5 Hz, 1H), 4.34 
(dd, J = 11.3, 7.0 Hz, 1H), 4.25 (dd, J = 11.3, 4.3 Hz, 1H), 4.20 (d, J = 13.5 Hz, 1H), 4.12 
(d, J = 7.0 Hz, 1H), 2.87 (qd, J = 6.8, 4.3 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 130.85 
, 129.33 , 129.07 , 128.66 , 128.61 , 128.29 , 128.08 , 127.32 , 126.53 , 121.24 , 117.22 , 
80.96 , 65.24 , 62.44 , 60.95 , 48.29 .  
 
4.5.4. Chromeoisoxazoles from Table 16. 
 
 
 
 
 
1-cyclohexyl-3-methyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 
column volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 
column volumes) yielded the isoxazolidine (19.2mg, 96%) as a yellow solid. TLC: Rf 0.5 
(3:1 heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.24 (dd, J = 8.8, 7.2 Hz, 1H), 7.15 
(ddd, J = 8.6, 7.5, 1.7 Hz, 1H), 6.94 (td, J = 7.5, 1.3 Hz, 1H), 6.82 (dd, J = 8.2, 1.2 Hz, 
1H), 4.30 (d, J = 7.2 Hz, 1H), 4.19 (d, J = 4.3 Hz, 2H), 4.07 (p, J = 6.3 Hz, 1H), 2.83 (tt, 
J = 10.9, 3.4 Hz, 1H), 2.43 (tt, J = 7.2, 4.3 Hz, 1H), 2.25 - 2.19 (m, 1H), 1.86 (d, J = 12.1 
Hz, 2H), 1.70 - 1.62 (m, 2H), 1.53 - 1.46 (m, 2H), 1.37 (d, J = 6.2 Hz, 3H), 1.32 - 1.23 
(m, 3H). 13C NMR (101 MHz, CDCl3) δ 130.57 , 128.60 , 121.31 , 116.82 , 64.33 , 62.57 
, 57.22 , 46.75 , 32.27 , 27.31 , 26.12 , 25.54 , 25.20 , 19.81 . 
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3-methyl-1-phenyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column 
volumes of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column 
volumes) yielded the isoxazolidine (19.0mg, 95%) as a brown solid. TLC: Rf 0.45 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.33 (dd, J = 8.6, 7.1 Hz, 2H), 7.25 (dd, 
J = 7.1, 1.6 Hz, 2H), 7.22 - 7.17 (m, 1H), 7.10 (dq, J = 7.2, 1.6 Hz, 2H), 6.92 - 6.86 (m, 
2H), 4.63 (d, J = 6.9 Hz, 1H), 4.35 - 4.29 (m, 1H), 4.26 (d, J = 3.6 Hz, 1H), 4.20 (dd, J = 
11.6, 5.5 Hz, 1H), 2.54 (tdd, J = 7.0, 5.4, 3.6 Hz, 1H), 1.52 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ 130.62 , 129.18 , 128.75 , 128.70 , 123.68 , 121.24 , 118.08 , 116.87 , 75.91 , 
64.48 , 64.19 , 46.51 , 19.90 . 
 
 
 
 
1,3-dimethyl-1,3a,4,9b-tetrahydro-3H-chromeno[4,3-c]isoxazole: Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 2 column volumes 
of 100% Heptanes followed by 0-15% EtOAc in Heptanes over 12 column volumes) 
yielded the isoxazolidine (18.8mg, 94%) as a white solid. TLC: Rf 0.33 (3:1 
heptanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.27 - 7.19 (m, 2H), 6.97 - 6.90 (m, 
2H), 4.15 - 4.06 (m, 2H), 4.00 - 3.92 (m, 1H), 3.48 (s, 1H), 2.85 (s, 3H), 2.45 (td, J = 7.9, 
7.4, 3.5 Hz, 1H), 1.39 (d, J = 6.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 130.66 , 
129.42 , 121.01 , 117.34 , 74.71 , 65.88 , 64.93 , 47.45 , 43.35 , 19.72  
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 4.5.5. 1H NMR and 13C NMR of Chromeoisoxazoles. 
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